<dl class="row">
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Showande SJ, Orok EN. Impact of pharmacists' training on oral anticoagulant counseling: A randomized controlled trial. Patient Educ Couns. 2021 May;104(5):1253-1259. doi: 10.1016/j.pec.2020.09.018. Epub 2020 Sep 17. PMID: 32998837. 
  </ref>
  <a><pmid>PMID32998837   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al-Babtain B, Cheema E, Hadi MA. Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials. Res Social Adm Pharm. 2021 Apr 29:S1551-7411(21)00163-7. doi: 10.1016/j.sapharm.2021.04.022. Epub ahead of print. PMID: 33965357. 
  </ref>
  <a><pmid>PMID33965357   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nakanishi M, Mizuno T, Mizokami F, Koseki T, Takahashi K, Tsuboi N, Katz M, Lee JK, Yamada S. Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: A meta-analysis of randomized clinical trials. J Clin Pharm Ther. 2021 Feb;46(1):114-120. doi: 10.1111/jcpt.13262. Epub 2020 Sep 19. PMID: 32949161. 
  </ref>
  <a><pmid>PMID32949161   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sud D, Laughton E, McAskill R, Bradley E, Maidment I. The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review. Syst Rev. 2021 Mar 31;10(1):92. doi: 10.1186/s13643-021-01586-9. PMID: 33789745; PMCID: PMC8015120. 
  </ref>
  <a><pmid>PMID33789745   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stuhec M, Flegar I, Zelko E, Kovačič A, Zabavnik V. Clinical pharmacist interventions in cardiovascular disease pharmacotherapy in elderly patients on excessive polypharmacy : A retrospective pre-post observational multicentric study. Wien Klin Wochenschr. 2021 Jan 20. doi: 10.1007/s00508-020-01801-y. Epub ahead of print. PMID: 33471149. 
  </ref>
  <a><pmid>PMID33471149   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gurwitz JH, Kapoor A, Garber L, Mazor KM, Wagner J, Cutrona SL, Singh S, Kanaan AO, Donovan JL, Crawford S, Anzuoni K, Konola TJ, Zhou Y, Field TS. Effect of a Multifaceted Clinical Pharmacist Intervention on Medication Safety After Hospitalization in Persons Prescribed High-risk Medications: A Randomized Clinical Trial. JAMA Intern Med. 2021 May 1;181(5):610-618. doi: 10.1001/jamainternmed.2020.9285. Erratum in: doi: 10.1001/jamainternmed.2021.2050. PMID: 33646267; PMCID: PMC7922235. 
  </ref>
  <a><pmid>PMID33646267   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Marra C, Gniadecki R, Keeling S, Morgan A, Tsuyuki R. RxIALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre-post intervention study. BMJ Open. 2021 Mar 24;11(3):e043612. doi: 10.1136/bmjopen-2020-043612. PMID: 33762234; PMCID: PMC7993291. 
  </ref>
  <a><pmid>PMID33762234   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hurst H, Dunn S, Fuji KT, Gilmore J, Wilt S, Webster S, Parikh P. Clinical impact of a pharmacist + health coach chronic disease management program in a rural free clinic. J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4):442-449. doi: 10.1016/j.japh.2021.02.014. Epub 2021 Feb 27. PMID: 33775539. 
  </ref>
  <a><pmid>PMID33775539   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Zongo A, Simpson S, Johnson JA, Eurich DT. Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension. J Manag Care Spec Pharm. 2021 Apr;27(4):426-434. PMID: 33769856. 
  </ref>
  <a><pmid>PMID33769856   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bakey KH, Nguyen CN. Impact of a Pharmacist Intervention in the Emergency Department on the Appropriateness of Direct Oral Anticoagulants Prescribed in Venous Thromboembolism Patients. J Pharm Pract. 2021 Mar 19:8971900211000704. doi: 10.1177/08971900211000704. Epub ahead of print. PMID: 33736522. 
  </ref>
  <a><pmid>PMID33736522   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rea K, Jadallah J, Nadpara P, Goode JK. Evaluation of the impact of a community-based, pharmacist-led weight loss program focused on a high-protein diet on risk factors for cardiovascular disease. J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4S):S147-S153. doi: 10.1016/j.japh.2021.01.027. Epub 2021 Feb 20. PMID: 33618987. 
  </ref>
  <a><pmid>PMID33618987   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nathans AM, Bhole R, Finch CK, George CM, Alexandrov AV, March KL. Impact of a Pharmacist-Driven Poststroke Transitions of Care Clinic on 30 and 90-Day Hospital Readmission Rates. J Stroke Cerebrovasc Dis. 2020;29(4):104648. doi:10.1016/j.jstrokecerebrovasdis.2020.104648 
  </ref>
  <a><pmid>PMID32033902   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dixon DL, Khaddage S, Bhagat S, Koenig RA, Salgado TM, Baker WL. Effect of pharmacist interventions on reducing low-density lipoprotein cholesterol (LDL-C) levels: A systematic review and meta-analysis. J Clin Lipidol. 2020;14(3):282-292.e4. doi:10.1016/j.jacl.2020.04.004 
  </ref>
  <a><pmid>PMID32418821   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Reeves L, Robinson K, McClelland T, Adedoyin CA, Broeseker A, Adunlin G. Pharmacist Interventions in the Management of Blood Pressure Control and Adherence to Antihypertensive Medications: A Systematic Review of Randomized Controlled Trials [published online ahead of print, 2020 Feb 18]. J Pharm Pract. 2020;897190020903573. doi:10.1177/0897190020903573 
  </ref>
  <a><pmid>PMID32067555   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Qin SB, Zhang XY, Fu Y, et al. The impact of the clinical pharmacist-led interventions in China: A systematic review and Meta-Analysis. Int J Clin Pharm. 2020;42(2):366-377. doi:10.1007/s11096-020-00972-y 
  </ref>
  <a><pmid>PMID32078109   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Newman TV, San-Juan-Rodriguez A, Parekh N, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review [published online ahead of print, 2020 Jan 14]. Res Social Adm Pharm. 2020;S1551-7411(19)30553-4. doi:10.1016/j.sapharm.2019.12.016 
  </ref>
  <a><pmid>PMID31959565   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Espinosa Y, Córdova PM, Fernández PB, Morales FE, Villa LA. Evaluating the Role of Clinical Pharmacists in Providing Pharmaceutical Care to Improve Adherence in Hypertensive Patients at a Rural Hospital in Southern Chile: A Pilot Study. J Res Pharm Pract. 2019;8(4):214-219. Published 2019 Dec 27. doi:10.4103/jrpp.JRPP_19_17 
  </ref>
  <a><pmid>PMID31956635   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jabri AM, Assad HC, Al-Jumaili AA. Pharmacist role to enhance the prescribing of hospital discharge medications for patients after heart attack. Saudi Pharm J. 2020;28(4):473-479. doi:10.1016/j.jsps.2020.02.009 
  </ref>
  <a><pmid>PMID32273807   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Neu R, Leonard MA, Dehoorne ML, Scalia SJ, Kale-Pradhan PB, Giuliano CA. Impact of Pharmacist Involvement in Heart Failure Transition of Care. Ann Pharmacother. 2020;54(3):239-246. doi:10.1177/1060028019882685 
  </ref>
  <a><pmid>PMID31602994   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Frederick A, Juan J, Ivy D, Maldonado YM. Effect of Visit Frequency of Pharmacist-Led Diabetes Medication Management Program. J Pharm Pract. 2020 Aug 24:897190020948685. doi: 10.1177/0897190020948685. Epub ahead of print. PMID: 32830604. 
  </ref>
  <a><pmid>PMID32830604   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lakey H, Boehmer K, Johnson C. Impact of a Pharmacist-Led Group Diabetes Class. J Pharm Pract. 2020 Aug 12:897190020948678. doi: 10.1177/0897190020948678. Epub ahead of print. PMID: 32783491. 
  </ref>
  <a><pmid>PMID32783491   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Norton MC, Haftman ME, Buzzard LN. Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use. J Am Board Fam Med. 2020 Sep-Oct;33(5):745-753. doi: 10.3122/jabfm.2020.05.200044. PMID: 32989069. 
  </ref>
  <a><pmid>PMID32989069   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chong MT. Pharmacist Interventions in Improving Clinical Outcomes in Patients with Type 2 Diabetes Mellitus Among the Underrepresented Population: A Collaborative Ambulatory Care Pharmacy Practice (CAPP) Approach. J Res Pharm Pract. 2020 Mar 28;9(1):3-9. doi: 10.4103/jrpp.JRPP_19_75. PMID: 32489954; PMCID: PMC7235450. 
  </ref>
  <a><pmid>PMID32489954   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Alsuwayni B, Alhossan A. Impact of clinical pharmacist-led diabetes management clinic on health outcomes at an academic hospital in Riyadh, Saudi Arabia: A prospective cohort study. Saudi Pharm J. 2020 Dec;28(12):1756-1759. doi: 10.1016/j.jsps.2020.11.002. Epub 2020 Nov 11. PMID: 33424266; PMCID: PMC7783205. 
  </ref>
  <a><pmid>PMID33424266   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Audurier Y, Chapet N, Renaudin P, Bons C, Mathieu B, Theret S, de Barry G, Jalabert A, Breuker C, Leclercq F, Pasquie JL, Agullo A, Roubille F, Castet-Nicolas A. Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients? Int J Clin Pract. 2020 Sep;74(9):e13531. doi: 10.1111/ijcp.13531. Epub 2020 May 27. PMID: 32459398. 
  </ref>
  <a><pmid>PMID32459398   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Qiu S, Wang N, Zhang C, Gu ZC, Qian Y. Anticoagulation Quality of Warfarin and the Role of Physician-Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study. Front Pharmacol. 2021 Jan 14;11:605353. doi: 10.3389/fphar.2020.605353. PMID: 33519468; PMCID: PMC7840488. 
  </ref>
  <a><pmid>PMID33519468   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McFarland MS, Thomas AM, Young E, Bryant C, Hughes JC, Hoffman J, Baker JW. Implementation and Effect of a Pharmacist-to-Pharmacist Transitions of Care Initiative on Ambulatory Care Sensitive Conditions. J Manag Care Spec Pharm. 2020 Apr;26(4):513-519. doi: 10.18553/jmcp.2020.26.4.513. PMID: 32223605. 
  </ref>
  <a><pmid>PMID32223605   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Watkins VA, Michaels NM, Jackson DL, Rhodes LA, Marciniak MW. The effect of community pharmacist-led health coaching on clinical outcomes. J Am Pharm Assoc (2003). 2020 May-Jun;60(3S):S65-S69. doi: 10.1016/j.japh.2020.03.021. Epub 2020 May 18. PMID: 32439280. 
  </ref>
  <a><pmid>PMID32439280   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Marcatto LR, Sacilotto L, Tavares LC, Souza DSP, Olivetti N, Strunz CMC, Darrieux FCC, Scanavacca MI, Krieger JE, Pereira AC, Santos PCJL. Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy. Front Pharmacol. 2020 Jul 14;11:1056. doi: 10.3389/fphar.2020.01056. PMID: 32765269; PMCID: PMC7381215. 
  </ref>
  <a><pmid>PMID32765269   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Johnson K, Kirby J, Kayse A, Brookhart A, Frede S, Hincapie A. Impact of an adherence intervention program on patient adherence and star ratings measures in a large community pharmacy chain. J Am Pharm Assoc (2003). 2020 Jul-Aug;60(4):e70-e78. doi: 10.1016/j.japh.2020.02.017. Epub 2020 Mar 27. PMID: 32229088. 
  </ref>
  <a><pmid>PMID32229088   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Huete L, Manzano-Lista FJ, Aránguez I, Fernández-Alfonso MS. Impact of
pharmacist's intervention on reducing cardiovascular risk in obese patients. Int J Clin Pharm. 2019 Jun 3. doi: 10.1007/s11096-019-00856-w. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID31161498   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Vincent R, Kim J, Ahmed T, Patel V. Pharmacist Statin Prescribing Initiative
in Diabetic Patients at an Internal Medicine Resident Clinic. J Pharm Pract. 2019
Jan 29:897190018824820. doi: 10.1177/0897190018824820. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30696337   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Berman T, Clark N, Lemieux AA. Impact of Pharmacist-Driven Heart Failure in-Home Counseling on 30-Day Readmission Rates. Prof Case Manag. 2019;24(4):194‐200. doi:10.1097/NCM.0000000000000332 
  </ref>
  <a><pmid>PMID31145238   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Koehl J, Steffenhagen A, Halfpap J. Implementation and Impact of Pharmacist-Initiated Home Medication Ordering in an Emergency Department Observation Unit [published online ahead of print, 2019 Oct 8]. J Pharm Pract. 2019;897190019879254. doi:10.1177/0897190019879254 
  </ref>
  <a><pmid>PMID31594429   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bahrami S, Chang C, Alvarez KS, Lutek K, Nguyen S, Hegde A. Pharmacist impact on health outcomes in a homeless population. J Am Pharm Assoc (2003). 2020;60(3):485-490. doi:10.1016/j.japh.2019.11.013 
  </ref>
  <a><pmid>PMID31901441   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lin CH, Tran NT, Muradian IK, et al. Impact of a Pharmacist-Led Diabetes Clinic in a Correctional Setting [published online ahead of print, 2019 Nov 19]. J Pharm Pract. 2019;897190019888075. doi:10.1177/0897190019888075 
  </ref>
  <a><pmid>PMID31742483   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Warden BA, Shapiro MD, Fazio S. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice. Ann Pharmacother. 2019;53(12):1214-1219. doi:10.1177/1060028019864669 
  </ref>
  <a><pmid>PMID31342786   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Alshehri AA, Jalal Z, Cheema E, Haque MS, Jenkins D, Yahyouche A. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29-38. doi:10.1111/bcp.14164 
  </ref>
  <a><pmid>PMID31777082   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wood M, Sweeney T, Trayah M, Civalier M, McMillian W. The Impact of Transitions of Care Pharmacist Services and Identification of Risk Predictors in Heart Failure Readmission [published online ahead of print, 2019 Oct 30]. J Pharm Pract. 2019;897190019884173. doi:10.1177/0897190019884173 
  </ref>
  <a><pmid>PMID31665955   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Blanchet M, Devillers N, Fournier A. Transmission d’une lettre de transfert d’information au pharmacien communautaire à la suite de l’hospitalisation d’un patient dans une unité de cardiologie. Pharmactuel. 2019;52(4):214-221. 
  </ref>
  <a><pmid>LID278   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hahn L, Belisle M, Nguyen S, Snackey Alvarez K, Das S. Effect of Pharmacist Clinic Visits on 30-Day Heart Failure Readmission Rates at a County Hospital. Hosp Pharm. 2019;54(6):358-364. doi:10.1177/0018578718797263 
  </ref>
  <a><pmid>PMID31762482   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nuffer W, Trujillo T, Griend JV. Estimated Potential Financial Impact of Pharmacist-Delivered Disease Management Services Across a Network of Pharmacies in Rural Colorado. J Manag Care Spec Pharm. 2019;25(9):984-988. doi:10.18553/jmcp.2019.25.9.984 
  </ref>
  <a><pmid>PMID31456492   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2019 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nuffer W, Trujillo T, Griend JV. Estimated Potential Financial Impact of Pharmacist-Delivered Disease Management Services Across a Network of Pharmacies in Rural Colorado. J Manag Care Spec Pharm. 2019;25(9):984-988. doi:10.18553/jmcp.2019.25.9.984 
  </ref>
  <a><pmid>PMID31456492   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Anderson C, Zhan K, Boyd M, Mann C. The role of pharmacists in general
practice: A realist review. Res Social Adm Pharm. 2019 Apr;15(4):338-345. doi:
10.1016/j.sapharm.2018.06.001. Epub 2018 Jun 12. Review. 
  </ref>
  <a><pmid>PMID29907317   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Amer M, Rahman N, Nazir SR, Raza A, Riaz H, Sultana M, Sadeeqa S. Impact of
pharmacist's intervention on disease related knowledge, medication adherence,
HRQoL and control of blood pressure among hypertensive patients. Pak J Pharm Sci.
2018 Nov;31(6 (Supplementary):2607-2616. 
  </ref>
  <a><pmid>PMID30587468   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pape ZA, Hale G, Joseph T, Moreau C, Wolowich WR. Impact of pharmacist-led heart failure tool kits on patient-reported self-care behaviors in a primary care-based accountable care organization. J Am Pharm Assoc (2003). 2019;59(6):891-895.e3. doi:10.1016/j.japh.2019.08.006 
  </ref>
  <a><pmid>PMID31582225   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cirot E, Samyn B, Van Nuvel E, Robert M, Doll G, Raphaël P. Mise en place d’un processus complet de pharmacie clinique en établissement de santé privé à but lucratif. J Pharm Clin. 2018;37(2):85-96. 
  </ref>
  <a><pmid>LID284   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A,
Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J,
Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.
Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance
Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes:
The STIC2IT Cluster Randomized Clinical Trial. JAMA Intern Med. 2018 Sep
1;178(9):1182-1189. doi: 10.1001/jamainternmed.2018.3189. 
  </ref>
  <a><pmid>PMID30083727   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Falamić S, Lucijanić M, Hadžiabdić MO, Marušić S, Bačić Vrca V. Pharmacist's
interventions improve time in therapeutic range of elderly rural patients on
warfarin therapy: a randomized trial. Int J Clin Pharm. 2018 Oct;40(5):1078-1085.
doi: 10.1007/s11096-018-0691-z. Epub 2018 Jul 26. 
  </ref>
  <a><pmid>PMID30051222   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fahs IM, Hallit S, Rahal MK, Malaeb DN. The Community Pharmacist's Role in
Reducing Cardiovascular Risk Factors in Lebanon: A Longitudinal Study. Med Princ Pract. 2018;27(6):508-514. doi: 10.1159/000490853. Epub 2018 Jun 13. 
  </ref>
  <a><pmid>PMID29898452   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sagita VA, Bahtiar A, Andrajati R. Evaluation of a Clinical Pharmacist
Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease
Inpatients: A pre-experimental prospective study at a general hospital in
Indonesia. Sultan Qaboos Univ Med J. 2018 Feb;18(1):e81-e87. doi:
10.18295/squmj.2018.18.01.013. Epub 2018 Apr 4. 
  </ref>
  <a><pmid>PMID29666686   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gobis B, Kapanen AI, Reardon J, Min J, Li KH, Lynd LD, Zed PJ. Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and
Medication Management by Pharmacists at the UBC Site). Ann Pharmacother. 2019
Jun;53(6):574-580. doi: 10.1177/1060028018823330. Epub 2019 Jan 13. 
  </ref>
  <a><pmid>PMID30638031   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yates L, Valente M, Wadsworth C. Evaluation of Pharmacist Medication Review
Service in an Outpatient Heart Failure Clinic. J Pharm Pract. 2019 May
5:897190019842696. doi: 10.1177/0897190019842696. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID31057060   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Casper EA, El Wakeel LM, Saleh MA, El-Hamamsy MH. Management of
pharmacotherapy-related problems in acute coronary syndrome: Role of clinical
pharmacist in cardiac rehabilitation unit. Basic Clin Pharmacol Toxicol. 2019
Jul;125(1):44-53. doi: 10.1111/bcpt.13210. Epub 2019 Apr 1. 
  </ref>
  <a><pmid>PMID30739389   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kennelty KA, Polgreen LA, Carter BL. Team-Based Care with Pharmacists to
Improve Blood Pressure: a Review of Recent Literature. Curr Hypertens Rep. 2018
Jan 18;20(1):1. doi: 10.1007/s11906-018-0803-0. Review. 
  </ref>
  <a><pmid>PMID29349522   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Saavedra-Mitjans M, Ferrand É, Garin N, Bussières JF. Role and impact of
pharmacists in Spain: a scoping review. Int J Clin Pharm. 2018
Dec;40(6):1430-1442. doi: 10.1007/s11096-018-0740-7. Epub 2018 Oct 26. Review. 
  </ref>
  <a><pmid>PMID30367376   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     San-Juan-Rodriguez A, Newman TV, Hernandez I, Swart ECS, Klein-Fedyshin M,
Shrank WH, Parekh N. Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: An umbrella review. Prev Med.
2018 Oct;115:145-155. doi: 10.1016/j.ypmed.2018.08.029. Epub 2018 Aug 23. 
  </ref>
  <a><pmid>PMID30145351   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ingram A, Valente M, Dzurec MA. Evaluating Pharmacist Impact on Guideline-Directed Medical Therapy in Patients With Reduced Ejection Fraction Heart Failure [published online ahead of print, 2019 Aug 11]. J Pharm Pract. 2019;897190019866930. doi:10.1177/0897190019866930 
  </ref>
  <a><pmid>PMID31401924   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Parajuli DR, Franzon J, McKinnon RA, Shakib S, Clark RA. Role of the
Pharmacist for Improving Self-care and Outcomes in Heart Failure. Curr Heart Fail
Rep. 2017 Apr;14(2):78-86. doi: 10.1007/s11897-017-0323-2. Review. 
  </ref>
  <a><pmid>PMID28233258   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Todd BA, Lamprecht DG Jr, Stadler SL. Pharmacist prescribing practices in a
clinical pharmacy cardiac risk service. Am J Health Syst Pharm. 2016 Sep
15;73(18):1442-50. doi: 10.2146/ajhp150781. 
  </ref>
  <a><pmid>PMID27605323   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sabater-Hernández D, Sabater-Galindo M, Fernandez-Llimos F, Rotta I, Hossain
LN, Durks D, Franco-Trigo L, Lopes LA, Correr CJ, Benrimoj SI. A Systematic
Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of
Cardiovascular Disease. J Manag Care Spec Pharm. 2016 Jun;22(6):699-713. doi:
10.18553/jmcp.2016.22.6.699. Review. 
  </ref>
  <a><pmid>PMID27231797   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     García-Molina Sáez C, Urbieta Sanz E, Madrigal de Torres M, Vicente Vera T,
Pérez Cárceles MD. Computerized pharmaceutical intervention to reduce
reconciliation errors at hospital discharge in Spain: an interrupted time-series study. J Clin Pharm Ther. 2016 Apr;41(2):203-8. doi: 10.1111/jcpt.12365. Epub
2016 Feb 25. 
  </ref>
  <a><pmid>PMID26916590   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Choumane NS, Malaeb DN, Malaeb B, Hallit S. A multicenter, prospective study
evaluating the impact of the clinical pharmacist-physician counselling on
warfarin therapy management in Lebanon. BMC Health Serv Res. 2018 Feb 1;18(1):80.
doi: 10.1186/s12913-018-2874-7. 
  </ref>
  <a><pmid>PMID29391010   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Zdyb EG, Courtney DM, Malik S, Schmidt MJ, Lyden AE. Impact of Discharge
Anticoagulation Education by Emergency Department Pharmacists at a Tertiary
Academic Medical Center. J Emerg Med. 2017 Dec;53(6):896-903. doi:
10.1016/j.jemermed.2017.06.008. Epub 2017 Sep 21. 
  </ref>
  <a><pmid>PMID28941557   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Waddles MN, Mitchell G, Snider MJ, Go MR, Attar T. Impact of clinical
pharmacists on atherosclerotic risk factor management in an integrated heart and vascular clinic. Vasc Med. 2018 Feb;23(1):80-81. doi: 10.1177/1358863X17747722.
Epub 2018 Jan 17. 
  </ref>
  <a><pmid>PMID29343178   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chavez B, Kosirog E, Brunner JM. Impact of a Bilingual Pharmacy Diabetes
Service in a Federally Qualified Health Center. Ann Pharmacother. 2018
Dec;52(12):1218-1223. doi: 10.1177/1060028018781852. Epub 2018 Jun 5. 
  </ref>
  <a><pmid>PMID29871511   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Oñatibia-Astibia A, Malet-Larrea A, Larrañaga B, Gastelurrutia MÁ, Calvo B,
Ramírez D, Cantero I, Garay Á, Goyenechea E. Tailored interventions by community pharmacists and general practitioners improve adherence to statins in a Spanish
randomized controlled trial. Health Serv Res. 2019 Jun;54(3):658-668. doi:
10.1111/1475-6773.13152. Epub 2019 Apr 7. 
  </ref>
  <a><pmid>PMID30957240   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sparks ER, Beavers JC. Evaluation of a Pharmacist-Driven Aldosterone
Antagonist Stewardship Program in Patients With Heart Failure. J Pharm Pract.
2019 Apr;32(2):158-162. doi: 10.1177/0897190017747083. Epub 2017 Dec 12. 
  </ref>
  <a><pmid>PMID29233053   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nelissen HE, Cremers AL, Okwor TJ, Kool S, van Leth F, Brewster L, Makinde O, Gerrets R, Hendriks ME, Schultsz C, Osibogun A, Van't Hoog AH. Pharmacy-based
hypertension care employing mHealth in Lagos, Nigeria - a mixed methods
feasibility study. BMC Health Serv Res. 2018 Dec 4;18(1):934. doi:
10.1186/s12913-018-3740-3. 
  </ref>
  <a><pmid>PMID30514376   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wright EA, Graham JH, Maeng D, Tusing L, Zaleski L, Martin R, Seipp R, Citsay B, McDonald B, Bolesta K, Chaundy K, Medico CJ, Gunderman S, Leri F, Guza K,
Price R, Gregor C, Parry DT. Reductions in 30-day readmission, mortality, and
costs with inpatient-to-community pharmacist follow-up. J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2):178-186. doi: 10.1016/j.japh.2018.11.005. Epub 2019 Jan 14. 
  </ref>
  <a><pmid>PMID30655090   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Budiman T, Snodgrass K, Komatsu Chang A. Evaluation of Pharmacist Medication
Education and Post-discharge Follow-up in Reducing Readmissions in Patients With ST-Segment Elevation Myocardial Infarction (STEMI). Ann Pharmacother. 2016
Feb;50(2):118-24. doi: 10.1177/1060028015620425. Epub 2015 Dec 17. 
  </ref>
  <a><pmid>PMID26681443   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. Effectiveness of
Community Pharmacist Prescribing and Care on Cardiovascular Risk Reduction:
Randomized Controlled RxEACH Trial. J Am Coll Cardiol. 2016 Mar 29. pii:
S0735-1097(16)32407-X. doi: 10.1016/j.jacc.2016.03.528. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID27058907   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Zhai XB, Gu ZC, Liu XY. Effectiveness of the clinical pharmacist in reducing
mortality in hospitalized cardiac patients: a propensity score-matched analysis. Ther Clin Risk Manag. 2016 Feb 18;12:241-50. doi: 10.2147/TCRM.S98300.
eCollection 2016. 
  </ref>
  <a><pmid>PMID26937196   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pousinho S, Morgado M, Falcão A, Alves G. Pharmacist Interventions in the
Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized
Controlled Trials. J Manag Care Spec Pharm. 2016 May;22(5):493-515. doi:
10.18553/jmcp.2016.22.5.493. 
  </ref>
  <a><pmid>PMID27123912   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hedegaard U, Kjeldsen LJ, Pottegård A, Henriksen JE, Lambrechtsen J, Hangaard J, Hallas J. Improving Medication Adherence in Patients with Hypertension: A
Randomized Trial. Am J Med. 2015 Dec;128(12):1351-61. doi:
10.1016/j.amjmed.2015.08.011. Epub 2015 Aug 21. 
  </ref>
  <a><pmid>PMID26302142   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jackevicius CA, de Leon NK, Lu L, Chang DS, Warner AL, Mody FV. Impact of a
Multidisciplinary Heart Failure Post-hospitalization Program on Heart Failure
Readmission Rates. Ann Pharmacother. 2015 Nov;49(11):1189-96. doi:
10.1177/1060028015599637. Epub 2015 Aug 10. 
  </ref>
  <a><pmid>PMID26259774   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Polgreen LA, Han J, Carter BL, Ardery GP, Coffey CS, Chrischilles EA, James
PA. Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to
Improve Blood Pressure Control. Hypertension. 2015 Dec;66(6):1145-51. doi:
10.1161/HYPERTENSIONAHA.115.06023. Epub 2015 Nov 2. 
  </ref>
  <a><pmid>PMID26527048   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, Egan B, Vander
Weg M, Chrischilles E, Vaughn T. Cluster-randomized trial of a
physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015 May;8(3):235-43. doi:
10.1161/CIRCOUTCOMES.114.001283. Epub 2015 Mar 24. 
  </ref>
  <a><pmid>PMID25805647   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Carter BL, Vander Weg MW, Parker CP, Goedken CC, Richardson KK, Rosenthal GE. Sustained Blood Pressure Control Following Discontinuation of a Pharmacist
Intervention for Veterans. J Clin Hypertens (Greenwich). 2015 Sep;17(9):701-8.
doi: 10.1111/jch.12577. Epub 2015 Jun 1. 
  </ref>
  <a><pmid>PMID26032843   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Salas CM, Miyares MA. Implementing a pharmacy resident run transition of care service for heart failure patients: Effect on readmission rates. Am J Health Syst Pharm. 2015 Jun 1;72(11 Suppl 1):S43-7. doi: 10.2146/sp150012. 
  </ref>
  <a><pmid>PMID25991595   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Soto A, Avila X, Cordova P, Fernandez P, Lopez M, Villa LA, Morales F. Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean hospital. Int J Clin Pharm. 2015 Oct;37(5):734-8.
doi: 10.1007/s11096-015-0131-2. Epub 2015 May 26. 
  </ref>
  <a><pmid>PMID26008218   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mohammed MA, Moles RJ, Chen TF. Impact of Pharmaceutical Care Interventions on
Health-Related Quality-of-Life Outcomes: A Systematic Review and Meta-analysis.
Ann Pharmacother. 2016 Oct;50(10):862-81. doi: 10.1177/1060028016656016. Review. 
  </ref>
  <a><pmid>PMID27363846   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Domingues EA, Ferrit-Martín M, Calleja-Hernández MÁ. Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy.
Int J Clin Pharm. 2017 Feb;39(1):52-60. doi: 10.1007/s11096-016-0387-1. Epub 2016
Nov 18. 
  </ref>
  <a><pmid>PMID27864732   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Domingues EA, Ferrit-Martín M, Calleja-Hernández MÁ. Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy.
Int J Clin Pharm. 2017 Feb;39(1):52-60. doi: 10.1007/s11096-016-0387-1. Epub 2016
Nov 18. 
  </ref>
  <a><pmid>PMID27864732   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Hemmelgarn BR, Hassan I, Jones CA, Tsuyuki RT. The
Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult
Patients with Type 2 Diabetes: The Multicentre Randomized Controlled R(x)EACH
Trial. Can J Diabetes. 2017 Dec;41(6):580-586. doi: 10.1016/j.jcjd.2017.08.244.
Epub 2017 Sep 28. 
  </ref>
  <a><pmid>PMID28965748   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Tsuyuki RT, Jones CA, Manns B, Tonelli M, Scott-Douglass N,
Jindal K, Tink W, Hemmelgarn BR. Effectiveness of Pharmacist Interventions on
Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized
Controlled R(x)EACH Trial. Am J Kidney Dis. 2018 Jan;71(1):42-51. doi:
10.1053/j.ajkd.2017.07.012. Epub 2017 Sep 12. 
  </ref>
  <a><pmid>PMID28912054   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kataruka A, Renner E, Barnes GD. Evaluating the role of clinical pharmacists
in pre-procedural anticoagulation management. Hosp Pract (1995). 2018
Feb;46(1):16-21. doi: 10.1080/21548331.2018.1420346. Epub 2017 Dec 28. 
  </ref>
  <a><pmid>PMID29283294   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Moye PM, Chu PS, Pounds T, Thurston MM. Impact of a pharmacy team-led
intervention program on the readmission rate of elderly patients with heart
failure. Am J Health Syst Pharm. 2018 Feb 15;75(4):183-190. doi:
10.2146/ajhp170256. 
  </ref>
  <a><pmid>PMID29436465   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tunney RK Jr, Johnson DC, Wang L, Cox ZL. Impact of Pharmacist Intervention to
Increase Compliance With Guideline-Directed Statin Therapy During an Acute
Coronary Syndrome Hospitalization. Ann Pharmacother. 2017 May;51(5):394-400. doi:
10.1177/1060028016687322. Epub 2017 Jan 6. 
  </ref>
  <a><pmid>PMID28058865   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Prudencio J, Cutler T, Roberts S, Marin S, Wilson M. The Effect of Clinical
Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home. J Manag Care Spec Pharm. 2018
May;24(5):423-429. doi: 10.18553/jmcp.2018.24.5.423. 
  </ref>
  <a><pmid>PMID29694290   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bonetti AF, Bagatim BQ, Mendes AM, Rotta I, Reis RC, Fávero MLD,
Fernandez-Llimós F, Pontarolo R. Impact of discharge medication counseling in the
cardiology unit of a tertiary hospital in Brazil: A randomized controlled trial. Clinics (Sao Paulo). 2018;73:e325. doi: 10.6061/clinics/2018/e325. Epub 2018 Apr 26. 
  </ref>
  <a><pmid>PMID29723341   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bonetti AF, Bagatim BQ, Mendes AM, Rotta I, Reis RC, Fávero MLD,
Fernandez-Llimós F, Pontarolo R. Impact of discharge medication counseling in the
cardiology unit of a tertiary hospital in Brazil: A randomized controlled trial. Clinics (Sao Paulo). 2018;73:e325. doi: 10.6061/clinics/2018/e325. Epub 2018 Apr 26. 
  </ref>
  <a><pmid>PMID29723341   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jones CD, Anthony A, Klein MD, Shakowski C, Smith HK, Go A, Perica K, Patel H, Pell J, Pierce R. The effect of a pharmacist-led multidisciplinary transitions-of-care pilot for patients at high risk of readmission. J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):554-560. doi: 10.1016/j.japh.2018.05.008. Epub 2018 Jul 17. 
  </ref>
  <a><pmid>PMID30017370   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Doggrell SA. A review of interventions ≥ 6 months by pharmacists on adherence to medicines in cardiovascular disease: Characteristics of what works and what
doesn't. Res Social Adm Pharm. 2019 Feb;15(2):119-129. doi:
10.1016/j.sapharm.2018.04.003. Epub 2018 Apr 6. Review. 
  </ref>
  <a><pmid>PMID29656935   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Okada H, Onda M, Shoji M, Sakane N, Nakagawa Y, Sozu T, Kitajima Y, Tsuyuki
RT, Nakayama T. Effects of lifestyle advice provided by pharmacists on blood
pressure: The COMmunity Pharmacists ASSist for Blood Pressure (COMPASS-BP)
randomized trial. Biosci Trends. 2018 Jan 9;11(6):632-639. doi:
10.5582/bst.2017.01256. Epub 2017 Dec 18. 
  </ref>
  <a><pmid>PMID29249774   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Goedken AM, Butler CM, McDonough RP, Deninger MJ, Doucette WR. Continuous
Medication Monitoring (CoMM): A foundational model to support the clinical work
of community pharmacists. Res Social Adm Pharm. 2018 Jan;14(1):106-111. doi:
10.1016/j.sapharm.2016.12.008. Epub 2017 Jan 2. 
  </ref>
  <a><pmid>PMID28087207   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Matzke GR, Moczygemba LR, Williams KJ, Czar MJ, Lee WT. Impact of a
pharmacist-physician collaborative care model on patient outcomes and health
services utilization. Am J Health Syst Pharm. 2018 Jul 15;75(14):1039-1047. doi: 10.2146/ajhp170789. Epub 2018 May 22. 
  </ref>
  <a><pmid>PMID29789318   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Plakogiannis R, Mola A, Sinha S, Stefanidis A, Oh H, Katz S. Impact of
Pharmacy Student-Driven Postdischarge Telephone Calls on Heart Failure Hospital
Readmission Rates: A Pilot Program. Hosp Pharm. 2019 Apr;54(2):100-104. doi:
10.1177/0018578718769243. Epub 2018 Apr 18. 
  </ref>
  <a><pmid>PMID30923402   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McKinley D, Moye-Dickerson P, Davis S, Akil A. Impact of a Pharmacist-Led
Intervention on 30-Day Readmission and Assessment of Factors Predictive of
Readmission in African American Men With Heart Failure. Am J Mens Health. 2019
Jan-Feb;13(1):1557988318814295. doi: 10.1177/1557988318814295. Epub 2018 Nov 28. 
  </ref>
  <a><pmid>PMID30486711   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Morath B, Mayer T, Send AFJ, Hoppe-Tichy T, Haefeli WE, Seidling HM. Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions: a review with a systematic approach. Br J Clin Pharmacol. 2017 Oct;83(10):2163-2178. doi: 10.1111/bcp.13318. Epub 2017 Jun 14. Review. 
  </ref>
  <a><pmid>PMID28452063   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients' medication adherence and other health outcomes: a
systematic review. Int J Pharm Pract. 2018 Oct;26(5):387-397. doi:
10.1111/ijpp.12462. Epub 2018 Jun 21. 
  </ref>
  <a><pmid>PMID29927005   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hovland R, Bremer S, Frigaard C, et al. Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies [published online ahead of print, 2019 Dec 29]. Int J Pharm Pract. 2019;10.1111/ijpp.12598. doi:10.1111/ijpp.12598 
  </ref>
  <a><pmid>PMID31886591   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aguiar PM, da Silva CH, Chiann C, Dórea EL, Lyra DP Jr, Storpirtis S.
Pharmacist-physician collaborative care model for patients with uncontrolled type
2 diabetes in Brazil: results from a randomized controlled trial. J Eval Clin
Pract. 2016 Jul 25. doi: 10.1111/jep.12606. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID27452158   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kang JE, Han NY, Oh JM, Jin HK, Kim HA, Son IJ, Rhie SJ. Pharmacist-involved
care for patients with heart failure and acute coronary syndrome: a systematic
review with qualitative and quantitative meta-analysis. J Clin Pharm Ther. 2016
Apr;41(2):145-57. doi: 10.1111/jcpt.12367. Epub 2016 Mar 7. Review. 
  </ref>
  <a><pmid>PMID26954666   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Parker CP, Cunningham CL, Carter BL, Vander Weg MW, Richardson KK, Rosenthal GE. A mixed-method approach to evaluate a pharmacist intervention for veterans with hypertension. J Clin Hypertens (Greenwich). 2014 Feb;16(2):133-40. doi: 10.1111/jch.12250. PubMed PMID: 24588813 
  </ref>
  <a><pmid>PMID24588813   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Selcuk A, Sancar M, Okuyan B, Demirtunc R, Izzettin FV. The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie.2015 Aug;70(8):559-62. PubMed PMID: 26380527. 
  </ref>
  <a><pmid>PMID26380527   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kalista T, Lemay V, Cohen L. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure. J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):438-42. doi: 10.1331/JAPhA.2015.14235. 
  </ref>
  <a><pmid>PMID26161487   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Boyé F, Sallerin B, Ah Kang F, Arnaud A, Kantambadouno JB, Amar J, Chamontin
B, Bouhanick B. [Place of clinical pharmacist in the management of drugs in
patients with hypertension]. Ann Cardiol Angeiol (Paris). 2015 Jun;64(3):216-21. doi: 10.1016/j.ancard.2015.04.003. Epub 2015 Jun 4. French. 
  </ref>
  <a><pmid>PMID26051854   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chen Z, Ernst ME, Ardery G, Xu Y, Carter BL. Physician-pharmacist
co-management and 24-hour blood pressure control. J Clin Hypertens (Greenwich).
2013 May;15(5):337-43. doi: 10.1111/jch.12077. Epub 2013 Feb 12. 
  </ref>
  <a><pmid>PMID23614849   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fortuna RJ, Nagel AK, Rose E, McCann R, Teeters JC, Quigley DD, Bisognano JD, Legette-Sobers S, Liu C, Rocco TA. Effectiveness of a multidisciplinary
intervention to improve hypertension control in an urban underserved practice. J Am Soc Hypertens. 2015 Dec;9(12):966-74. doi: 10.1016/j.jash.2015.10.004. Epub
2015 Oct 26. 
  </ref>
  <a><pmid>PMID26687551   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc
Ther. 2015 Feb;13(2):209-21. doi: 10.1586/14779072.2015.1001368. Epub 2015 Jan
12. Review. 
  </ref>
  <a><pmid>PMID25578090   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Carter BL, Levy BT, Gryzlak B, Chrischilles EA, Vander Weg MW, Christensen AJ,
James PA, Moss CA, Parker CP, Gums T, Finkelstein RJ, Xu Y, Dawson JD, Polgreen
LA. A centralized cardiovascular risk service to improve guideline adherence in
private primary care offices. Contemp Clin Trials. 2015 Jul;43:25-32. doi:
10.1016/j.cct.2015.04.014. Epub 2015 May 4. 
  </ref>
  <a><pmid>PMID25952471   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Andres J, Stanton-Ameisen O, Walton S, Ruchalski C. Pharmacists' Impact on
Secondary Stroke Prevention. J Pharm Pract. 2018 Jan 1:897190018766944. doi:
10.1177/0897190018766944. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID29591369   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Maeng DD, Graham J, Bogart M, Hao J, Wright EA. Impact of a pharmacist-led
diabetes management on outcomes, utilization, and cost. Clinicoecon Outcomes Res.
2018 Sep 24;10:551-562. doi: 10.2147/CEOR.S174595. eCollection 2018. 
  </ref>
  <a><pmid>PMID30288070   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cheema E, Sutcliffe P, Weickert MO, Singer DRJ. A randomised controlled trial of the impact of structured written and verbal advice by community pharmacists on
improving hypertension education and control in patients with high blood
pressure. Eur J Clin Pharmacol. 2018 Nov;74(11):1391-1395. doi:
10.1007/s00228-018-2519-0. Epub 2018 Jul 18. 
  </ref>
  <a><pmid>PMID30022334   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gatwood JD, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, Shawn McFarland M, Kovesdy CP. Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes. BMC Health Serv Res. 2018 Nov 14;18(1):855. doi: 10.1186/s12913-018-3665-x. 
  </ref>
  <a><pmid>PMID30428877   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hall NJ, Donovan G, Wilkes S. A qualitative synthesis of pharmacist, other
health professional and lay perspectives on the role of community pharmacy in
facilitating care for people with long-term conditions. Res Social Adm Pharm.
2018 Nov;14(11):1043-1057. doi: 10.1016/j.sapharm.2018.01.002. Epub 2018 Jan 4. 
  </ref>
  <a><pmid>PMID29331530   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chastang A, Renet S, Corny J, Beaussier H, Petre A, Lillo-Lelouet A, Phan Thi TT, Bézie Y. Impact of hospital pharmacist interventions on the combination of
citalopram or escitalopram with other QT-prolonging drugs. Int J Clin Pharm. 2019
Feb;41(1):42-48. doi: 10.1007/s11096-018-0724-7. Epub 2019 Jan 4. 
  </ref>
  <a><pmid>PMID30610545   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chiou CC, Tsai TH, Lee CH, et al. Impact of Pharmacist Interventions on the Long-Term Clinical Outcomes in Patients with Myocardial Infarction. Acta Cardiol Sin. 2019;35(3):290‐300. doi:10.6515/ACS.201905_35(3).20181122B 
  </ref>
  <a><pmid>PMID31249459   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Roblek T, Deticek A, Leskovar B, Suskovic S, Horvat M, Belic A, Mrhar A,
Lainscak M. Clinical-pharmacist intervention reduces clinically relevant
drug-drug interactions in patients with heart failure: A randomized,
double-blind, controlled trial. Int J Cardiol. 2016 Jan 15;203:647-52. doi:
10.1016/j.ijcard.2015.10.206. Epub 2015 Oct 28. 
  </ref>
  <a><pmid>PMID26580349   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Luder HR, Frede SM, Kirby JA, Epplen K, Cavanaugh T, Martin-Boone JE, Conrad WF, Kuhlmann D, Heaton PC. TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate. J Am Pharm Assoc (2003). 2015 May-Jun;55(3):246-54. doi: 10.1331/JAPhA.2015.14060. 
  </ref>
  <a><pmid>PMID26003155   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bleske BE, Dillman NO, Cornelius D, Ward JK, Burson SC, Diez HL, Pickworth KK, Bennett MS, Nicklas JM, Dorsch MP. Heart failure assessment at the community pharmacy level: a feasibility pilot study. J Am Pharm Assoc (2003). 2014 Nov-Dec;54(6):634-41. doi: 10.1331/JAPhA.2014.14039. PubMed PMID: 25379983 
  </ref>
  <a><pmid>PMID25379983   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Milfred-LaForest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL 2nd, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy. 2013 May;33(5):529-48. doi: 10.1002/phar.1295. PubMed PMID: 23649813 
  </ref>
  <a><pmid>PMID23649813   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Davis EM, Packard KA, Jackevicius CA. The pharmacist role in predicting and improving medication adherence in heart failure patients. J Manag Care Spec Pharm. 2014 Jul;20(7):741-55. Review. PubMed PMID: 24967527 
  </ref>
  <a><pmid>PMID24967527   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cheng JW, Cooke-Ariel H. Pharmacists' role in the care of patients with heart  failure: review and future evolution. J Manag Care Pharm. 2014 Feb;20(2):206-13.  PubMed PMID: 24456323 
  </ref>
  <a><pmid>PMID24456323   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014 Dec;78(6):1238-47. doi: 10.1111/bcp.12452. PubMed PMID: 24966032; PubMed Central PMCID: PMC4256613 
  </ref>
  <a><pmid>PMID24966032   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, Burnand B, Paradis G. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014 Apr 10;3(2):e000718. doi: 10.1161/JAHA.113.000718. Review. PubMed PMID: 24721801; PubMed Central PMCID: PMC4187511 
  </ref>
  <a><pmid>PMID24721801   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Magalhães GF, Santos GB, Rosa MB, Noblat Lde A. Medication reconciliation in patients hospitalized in a cardiology unit. PLoS One. 2014 Dec 22;9(12):e115491. doi: 10.1371/journal.pone.0115491. eCollection 2014. PubMed PMID: 25531902; PubMed Central PMCID: PMC4274082. 
  </ref>
  <a><pmid>PMID25531902   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kitts NK, Reeve AR, Tsu L. Care transitions in elderly heart failure patients: current practices and the pharmacist's role. Consult Pharm. 2014 Mar;29(3):179-90. doi: 10.4140/TCP.n.2014.179. Review. PubMed PMID: 24589767 
  </ref>
  <a><pmid>PMID24589767   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Weitzel KW, Elsey AR, Langaee TY, Burkley B, Nessl DR, Obeng AO, Staley BJ, Dong HJ, Allan RW, Liu JF, Cooper-Dehoff RM, Anderson RD, Conlon M, Clare-Salzler MJ, Nelson DR, Johnson JA. Clinical pharmacogenetics implementation: approaches, successes, and challenges. Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):56-67. doi: 10.1002/ajmg.c.31390. Epub 2014 Mar 10. PubMed PMID: 24616371; PubMed Central PMCID: PMC4076109 
  </ref>
  <a><pmid>PMID24616371   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sohn HS, Jang S, Lee JY, Han E. Patient response to insurer-led intervention for medication adherence - a pilot study based on claims data in Korea. Int J Clin Pharmacol Ther. 2016 Jan;54(1):28-35. 
  </ref>
  <a><pmid>PMID26413729   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Elliott RA, Boyd MJ, Salema NE, Davies J, Barber N, Mehta RL, Tanajewski L,
Waring J, Latif A, Gkountouras G, Avery AJ, Chuter A, Craig C. Supporting
adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine
Service. BMJ Qual Saf. 2015 Dec 8. pii: bmjqs-2015-004400. doi:
10.1136/bmjqs-2015-004400. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID26647412   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Zhai XB, Tian DD, Liu XY. The role of the clinical pharmacist in reducing
mortality in hospitalized cardiac patients: A prospective, nonrandomized
controlled trial using propensity score methods. Int J Clin Pharmacol Ther. 2015 Mar;53(3):220-9. doi: 10.5414/CP202111. 
  </ref>
  <a><pmid>PMID25546163   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lee VW, Choi LM, Wong WJ, Chung HW, Ng CK, Cheng FW. Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community. BMC Cardiovasc Disord. 2015 Dec 24;15(1):178. 
  </ref>
  <a><pmid>PMID26702612   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dempsey JT, Matta LS, Carter DM, Stevens CA, Stevenson LW, Desai AS, Cheng JW.
Assessment of Drug Therapy-Related Issues in an Outpatient Heart Failure
Population and the Potential Impact of Pharmacist-Driven Intervention. J Pharm
Pract. 2016 Apr 13. pii: 0897190016641491. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID27080398   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Balling L, Erstad BL, Weibel K. Impact of a transition-of-care pharmacist
during hospital discharge. J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):443-8.
doi: 10.1331/JAPhA.2015.14087. 
  </ref>
  <a><pmid>PMID26161488   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Khalil V, Li M, Hua QA. An audit of the pharmacological management of ischaemic stroke patients in a metropolitan Australian hospital. Int J Clin Pharm. 2015 Feb;37(1):8-11. doi: 10.1007/s11096-014-0035-6. Epub 2014 Nov 15. 
  </ref>
  <a><pmid>PMID25394833   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Migliozzi DR, Zullo AR, Collins C, Elsaid KA. Achieving blood pressure control
among renal transplant recipients by integrating electronic health technology and
clinical pharmacy services. Am J Health Syst Pharm. 2015 Nov 15;72(22):1987-92.
doi: 10.2146/ajhp140810. 
  </ref>
  <a><pmid>PMID26541954   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Smith SM, Hasan M, Huebschmann AG, Penaloza R, Schorr-Ratzlaff W, Sieja A, Roscoe N, Trinkley KE. Physician Acceptance of a Physician-Pharmacist Collaborative Treatment Model for Hypertension Management in Primary Care. J Clin Hypertens (Greenwich). 2015 Sep;17(9):686-91. doi: 10.1111/jch.12575. Epub 2015 Jun 1. 
  </ref>
  <a><pmid>PMID26032586   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gunadi S, Upfield S, Pham ND, Yea J, Schmiedeberg MB, Stahmer GD. Development of a collaborative transitions-of-care program for heart failure patients. Am J Health Syst Pharm. 2015 Jul 1;72(13):1147-52. doi: 10.2146/ajhp140563. 
  </ref>
  <a><pmid>PMID26092965   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Salles M, Amet D, Archer V, Elbaz N, Teiger E, Paul M, Astier A. [Evaluation
of ownership of an implantable medical device by patients]. Ann Pharm Fr. 2013
Nov;71(6):423-8. doi: 10.1016/j.pharma.2013.06.004. French. 
  </ref>
  <a><pmid>PMID24206595   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chamoun NR, Zeenny R, Mansour H. Impact of clinical pharmacy interventions on medication error nodes. Int J Clin Pharm. 2016 Dec;38(6):1436-1444. Epub 2016 Oct
21. 
  </ref>
  <a><pmid>PMID27770350   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Davis CS, Ross LAR, Bloodworth LS. The Impact of Clinical Pharmacist Integration on a Collaborative Interdisciplinary Diabetes Management Team. J Pharm Pract. 2017 Jun;30(3):286-290. doi: 10.1177/0897190016631894. Epub 2016 Feb 17. 
  </ref>
  <a><pmid>PMID26888261   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hale GM, Hassan SL, Hummel SL, Lewis C, Ratz D, Brenner M. Impact of a
Pharmacist-Managed Heart Failure Postdischarge (Bridge) Clinic for Veterans. Ann Pharmacother. 2017 Jul;51(7):555-562. doi: 10.1177/1060028017698974. Epub 2017
Mar 9. 
  </ref>
  <a><pmid>PMID28622740   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Quinones ME, Pio MY, Chow DH, Moss E, Hulstein JL, Boatright SM, Mathew A.
Impact of clinical pharmacy services on outcomes and costs for indigent patients with diabetes. Am J Manag Care. 2016 Apr 1;22(4):e147-52. 
  </ref>
  <a><pmid>PMID27143351   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Anderegg MD, Gums TH, Uribe L, MacLaughlin EJ, Hoehns J, Bazaldua OV, Ives TJ,
Hahn DL, Coffey CS, Carter BL. Pharmacist Intervention for Blood Pressure Control
in Patients with Diabetes and/or Chronic Kidney Disease. Pharmacotherapy. 2018
Mar;38(3):309-318. doi: 10.1002/phar.2083. Epub 2018 Feb 23. 
  </ref>
  <a><pmid>PMID29331037   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Guédat MG, Gouraud A, Ramiah T, Demazière J, Delanoy B, Vial T, Leboucher G, Charpiat B. [Clinical pharmacy and pharmacovigilance over a period of nine years in hospital]. Therapie. 2012 May-Jun;67(3):243-50. 
  </ref>
  <a><pmid>PMID22874491   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Barker A, Barlis P, Berlowitz D, Page K, Jackson B, Lim WK. Pharmacist directed home medication reviews in patients with chronic heart failure: a randomised clinical trial. Int J Cardiol. 2012 Aug 23;159(2):139-43. 
  </ref>
  <a><pmid>PMID21392837   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sperandio da Silva GM, Chambela MC, Sousa AS, Sangenis LH, Xavier SS, Costa AR, Brasil PE, Hasslocher-Moreno AM, Saraiva RM. Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial. Trials. 2012 Dec 27;13:244. 
  </ref>
  <a><pmid>PMID23270509   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Houle SK, Chuck AW, McAlister FA, Tsuyuki RT. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Pharmacotherapy. 2012 Jun;32(6):527-37. 
  </ref>
  <a><pmid>PMID22552863   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Thomas R, Huntley AL, Mann M, Huws D, Elwyn G, Paranjothy S, Purdy S. Pharmacist-led interventions to reduce unplanned admissions for older people: a systematic review and meta-analysis of randomised controlled trials. Age Ageing. 2014 Mar;43(2):174-87. doi: 10.1093/ageing/aft169. Epub 2013 Nov 5. Review. PubMed PMID: 24196278 
  </ref>
  <a><pmid>PMID24196278   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cai H, Dai H, Hu Y, Yan X, Xu H. Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. BMC Health Serv Res. 2013 Nov 4;13:461. doi: 10.1186/1472-6963-13-461. Review. PubMed PMID: 24188540; PubMed Central PMCID: PMC4228353 
  </ref>
  <a><pmid>PMID24188540   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Penm J, Li Y, Zhai S, Hu Y, Chaar B, Moles R. The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China's current healthcare reform. Health Policy Plan. 2014 Oct;29(7):849-872.Epub 2013 Sep 19. Review. PubMed PMID: 24056897 
  </ref>
  <a><pmid>PMID24056897   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012 Dec;35(12):2706-17. doi: 10.2337/dc12-0369. Review. PubMed PMID: 23173140; PubMed Central PMCID: PMC3507563. 
  </ref>
  <a><pmid>PMID23173140   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Szkiladz A, Carey K, Ackerbauer K, Heelon M, Friderici J, Kopcza K. Impact of pharmacy student and resident-led discharge counseling on heart failure patients. J Pharm Pract. 2013 Dec;26(6):574-9. PubMed PMID: 23797199 
  </ref>
  <a><pmid>PMID23797199   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Martinez AS, Saef J, Paszczuk A, Bhatt-Chugani H. Implementation of a pharmacist-managed heart failure medication titration clinic. Am J Health Syst Pharm. 2013 Jun 15;70(12):1070-6. doi: 10.2146/ajhp120267. PubMed PMID: 23719886. 
  </ref>
  <a><pmid>PMID23719886   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Israel EN, Farley TM, Farris KB, Carter BL. Underutilization of cardiovascular medications: effect of a continuity-of-care program. Am J Health Syst Pharm. 2013 Sep 15;70(18):1592-600. doi: 10.2146/ajhp120786. PubMed PMID: 23988600; PubMed Central PMCID: PMC4019344 
  </ref>
  <a><pmid>PMID23988600   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hetro A, Rossetto J, Bahlawan N, Ryan M. Clinical pharmacists supporting patients with diabetes and/or hyperlipidemia in a military medical home. J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):73-6. doi: 10.1331/JAPhA.2015.14103. PubMed PMID: 25539358 
  </ref>
  <a><pmid>PMID25539358   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Buck B, Dean N,  Bakal JA, Tsuyuki R, Grover S, Shuaib A. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ. 2014 May 13;186(8):577-84. doi: 10.1503/cmaj.140053. Epub 2014 Apr 14. Erratum in: CMAJ. 2014 Jun 10;186(9):698. PubMed PMID: 24733770; PubMed Central PMCID: PMC4016053 
  </ref>
  <a><pmid>PMID24733770   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Schneiderhan ME, Shuster SM, Davey CS. Twelve-month prospective randomized study of pharmacists utilizing point-of-care testing for metabolic syndrome and related conditions in subjects prescribed antipsychotics. Prim Care Companion CNS Disord. 2014 Oct 30;16(5). Doi: 10.4088/PCC.14m01669. eCollection 2014. PubMed PMID: 25667811; PubMed Central PMCID: PMC4321016 
  </ref>
  <a><pmid>PMID25667811   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shoulders BR, Franks AS, Barlow PB, Williams JD, Farland MZ. Impact of pharmacists' interventions and simvastatin dose restrictions. Ann Pharmacother. 2014 Jan;48(1):54-61. doi: 10.1177/1060028013511323. Epub 2013 Nov 6. PubMed PMID: 24259645 
  </ref>
  <a><pmid>PMID24259645   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, Bosworth HB, Radcliff T, Davis R, Mun H, Weaver J, Barnett C, Barón A, Del Giacco EJ. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014 Feb 1;174(2):186-93. doi: 10.1001/jamainternmed.2013.12944. PubMed PMID: 24247275. 
  </ref>
  <a><pmid>PMID24247275   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, Singh RF, Wood Y, Kaplan RM, Mangione CM. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014 Sep 1;36(9):1244-54. doi: 10.1016/j.clinthera.2014.06.030. Epub 2014 Jul 30. PubMed PMID: 25085406; PubMed Central PMCID: PMC4169745 
  </ref>
  <a><pmid>PMID25085406   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Houle SK, Chatterley T, Tsuyuki RT. Multidisciplinary approaches to the management of high blood pressure. Curr Opin Cardiol. 2014 Jul;29(4):344-53. doi: 10.1097/HCO.0000000000000071. Review. PubMed PMID: 25029452 
  </ref>
  <a><pmid>PMID25029452   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aag T, Garcia BH, Viktil KK. Should nurses or clinical pharmacists perform medication reconciliation? A randomized controlled trial. Eur J Clin Pharmacol. 2014 Nov;70(11):1325-32. doi: 10.1007/s00228-014-1741-7. Epub 2014 Sep 4. PubMed PMID: 25187339. 
  </ref>
  <a><pmid>PMID25187339   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Farley TM, Shelsky C, Powell S, Farris KB, Carter BL. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014 Apr;36(2):430-7. doi: 10.1007/s11096-014-9917-x. Epub 2014 Feb 11. PubMed PMID: 24515550; PubMed Central PMCID: PMC4026363. 
  </ref>
  <a><pmid>PMID24515550   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Adams J, Cymbala AA, Delate T, Kurz D, Olson KL, Youngblood M, Zadvorny E. Cluster-Randomized Trial of Clinical Pharmacist Tobacco Cessation Counseling among Patients with Cardiovascular Disease. Popul Health Manag. 2015 Feb 3. [Epub ahead of print] PubMed PMID: 25647441. 
  </ref>
  <a><pmid>PMID25647441   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Donaho EK, Hall AC, Gass JA, Elayda MA, Lee VV, Paire S, Meyers DE.
Protocol-Driven Allied Health Post-Discharge Transition Clinic to Reduce Hospital
Readmissions in Heart Failure. J Am Heart Assoc. 2015 Dec 23;4(12). pii: e002296.
doi: 10.1161/JAHA.115.002296. 
  </ref>
  <a><pmid>PMID26702083   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Truong JT, Backes AC. The impact of a Continuum of Care Resident Pharmacist on
heart failure readmissions and discharge instructions at a community hospital.
SAGE Open Med. 2015 Mar 30;3:2050312115577986. doi: 10.1177/2050312115577986.
eCollection 2015. 
  </ref>
  <a><pmid>PMID26770775   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sabry N, Farid S, Dawoud D. Drug-related problems in cardiac children. Minerva
Pediatr. 2016 Apr;68(2):89-95. Epub 2014 Jul 18. 
  </ref>
  <a><pmid>PMID25034220   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ramanath K, Balaji D, Nagakishore Ch, Kumar SM, Bhanuprakash M. A study on
impact of clinical pharmacist interventions on medication adherence and quality
of life in rural hypertensive patients. J Young Pharm. 2012 Apr;4(2):95-100. doi:
10.4103/0975-1483.96623. 
  </ref>
  <a><pmid>PMID22754261   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Shore S, Ho PM, Lambert-Kerzner A, Glorioso TJ, Carey EP, Cunningham F, Longo L, Jackevicius C, Rose A, Turakhia MP. Site-level variation in and practices
associated with dabigatran adherence. JAMA. 2015 Apr 14;313(14):1443-50. doi:
10.1001/jama.2015.2761. 
  </ref>
  <a><pmid>PMID25871670   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tavernier, J., Dupont, H., Philippe, L., Cottin, Y., Guenfoudi, M. P., &amp; Garnier, N. (2015). Gestion du risque et stent actif. Évaluation régionale des pratiques professionnelles en cardiologie interventionnelle. Le Pharmacien Hospitalier et Clinicien, 50(1), 93-98. 
  </ref>
  <a><pmid>LID256   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2011 Jan;34(1):20-6. Epub 2010 Oct 7 
  </ref>
  <a><pmid>PMID20929988   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Beloin-Jubinville B, Joly-Mischlich T, Rouleau ED, Noiseux P, Blais L, Forget A, Beauchesne MF. Does hospitalization influence patients' medication adherence and community pharmacists' interventions? . Ann Pharmacother. 2013 Sep;47(9):1143-52. doi: 10.1177/1060028013503123. 
  </ref>
  <a><pmid>PMID24259729   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wallgren S, Berry-Cabán CS, Bowers L. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility. Ann Pharmacother. 2012 Mar;46(3):353-7. 
  </ref>
  <a><pmid>PMID22395249   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kaasalainen S, Strachan PH, Brazil K, Marshall D, Willison K, Dolovich L, Taniguchi A, Demers C. Managing palliative care for adults with advanced heart failure. Can J Nurs Res. 2011 Sep;43(3):38-57. 
  </ref>
  <a><pmid>PMID21977725   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lambert-Kerzner A, Del Giacco EJ, Fahdi IE, Bryson CL, Melnyk SD, Bosworth HB,
Davis R, Mun H, Weaver J, Barnett C, Radcliff T, Hubbard A, Bosket KD, Carey E,
Virchow A, Mihalko-Corbitt R, Kaufman A, Marchant-Miros K, Ho PM; Multifaceted
Intervention to Improve Cardiac Medication Adherence and Secondary Prevention
Measures (Medication) Study Investigators. Patient-centered adherence
intervention after acute coronary syndrome hospitalization. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):571-6. doi: 10.1161/CIRCOUTCOMES.111.962290. 
  </ref>
  <a><pmid>PMID22811499   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lalonde L, Hudon E, Goudreau J, Bélanger D, Villeneuve J, Perreault S, Blais L, Lamarre D. Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients. Res Social Adm Pharm. 2011 Sep;7(3):233-45. 
  </ref>
  <a><pmid>PMID21272548   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lalonde L, Hudon E, Goudreau J, Bélanger D, Villeneuve J, Perreault S, Blais L, Lamarre D. Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients. Res Social Adm Pharm. 2011 Sep;7(3):233-45. 
  </ref>
  <a><pmid>PMID21272548   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aslani P, Rose G, Chen TF, Whitehead PA, Krass I. A community pharmacist delivered adherence support service for dyslipidaemia. Eur J Public Health. 2011 Oct;21(5):567-72. 
  </ref>
  <a><pmid>PMID20817685   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aguiar PM, Balisa-Rocha BJ, Brito Gde C, da Silva WB, Machado M, Lyra DP Jr. Pharmaceutical care in hypertensive patients: a systematic literature review. Res Social Adm Pharm. 2012 Sep-Oct;8(5):383-96. 
  </ref>
  <a><pmid>PMID22222348   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Blalock SJ, Roberts AW, Lauffenburger JC, Thompson T, O'Connor SK. The effect  of community pharmacy-based interventions on patient health outcomes: a systematic review. Med Care Res Rev. 2013 Jun;70(3):235-66. doi: 10.1177/1077558712459215. Epub 2012 Oct 2. Review. 
  </ref>
  <a><pmid>PMID23035056   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lekura J, Tita C, Lanfear DE, Williams CT, Jennings DL. Assessing the potential of e-mail for communicating drug therapy recommendations to physicians  in patients with heart failure and ventricular-assist devices. J Pharm Pract. 2014 Oct;27(5):478-80. doi: 10.1177/0897190013513618. Epub 2013 Dec 6. PubMed PMID: 24319078 
  </ref>
  <a><pmid>PMID24319078   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Warden BA, Freels JP, Furuno JP, Mackay J. Pharmacy-managed program for providing education and discharge instructions for patients with heart failure. Am J Health Syst Pharm. 2014 Jan 15;71(2):134-9. doi: 10.2146/ajhp130103. PubMed PMID: 24375606. 
  </ref>
  <a><pmid>PMID24375606   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dorsch MP, Lose JM, DiDomenico RJ. The effect of cardiovascular credentialed pharmacists on process measures and outcomes in myocardial infarction and heart failure. Pharmacotherapy. 2014 Aug;34(8):803-8. doi: 10.1002/phar.1444. Epub 2014 Jun 5. PubMed PMID: 24898104 
  </ref>
  <a><pmid>PMID24898104   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Wong MC, Liu KQ, Wang HH, Lee CL, Kwan MW, Lee KW, Cheung Y, Lee GK, Morisky DE, Griffiths SM. Effectiveness of a pharmacist-led drug counseling on enhancing  antihypertensive adherence and blood pressure control: a randomized controlled trial. J Clin Pharmacol. 2013 Jul;53(7):753-61. doi: 10.1002/jcph.101. Epub 2013  May 16. PubMed PMID: 23677794. 
  </ref>
  <a><pmid>PMID23677794   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gujral G, Winckel K, Nissen LM, Cottrell WN. Impact of community pharmacist intervention discussing patients' beliefs to improve medication adherence. Int J Clin Pharm. 2014 Oct;36(5):1048-58. doi: 10.1007/s11096-014-9993-y. Epub 2014 Aug 19. PubMed PMID: 25135805. 
  </ref>
  <a><pmid>PMID25135805   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stange D, Kriston L, von-Wolff A, Baehr M, Dartsch DC. Reducing cardiovascular medication complexity in a German university hospital: effects of a structured pharmaceutical management intervention on adherence. J Manag Care Pharm. 2013 Jun;19(5):396-407. PubMed PMID: 23697477. 
  </ref>
  <a><pmid>PMID23697477   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Henry TM, Smith S, Hicho M. Treat to goal: impact of clinical pharmacist referral service primarily in diabetes management. Hosp Pharm. 2013 Sep;48(8):656-61. doi: 10.1310/hpj4808-656. PubMed PMID: 24421536; PubMed Central PMCID: PMC3847985. 
  </ref>
  <a><pmid>PMID24421536   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Spence MM, Makarem AF, Reyes SL, Rosa LL, Nguyen C, Oyekan EA, Kiyohara AT. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease. J Manag Care Spec Pharm. 2014 Oct;20(10):1036-45. PubMed PMID: 25278326. 
  </ref>
  <a><pmid>PMID25278326   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Van Berkel MA, Crannage AJ, Murphy JA. Evaluation of education on the appropriate use of vitamin k in warfarin reversal in adult inpatients. Hosp Pharm. 2013 Sep;48(8):662-7. doi: 10.1310/hpj4808-662. PubMed PMID: 24421537; PubMed Central PMCID: PMC3847984 
  </ref>
  <a><pmid>PMID24421537   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aljbouri TM, Alkhawaldeh MS, Abu-Rumman AE, Hasan TA, Khattar HM, Abu-Oliem AS. Impact of clinical pharmacist on cost of drug therapy in the ICU. Saudi Pharm J. 2013 Oct;21(4):371-4. doi: 10.1016/j.jsps.2012.12.004. PubMed PMID: 24227956; PubMed Central PMCID: PMC3824941. 
  </ref>
  <a><pmid>PMID24227956   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     O'Neill JL, Cunningham TL, Wiitala WL, Bartley EP. Collaborative hypertension case management by registered nurses and clinical pharmacy specialists within the
Patient Aligned Care Teams (PACT) model. J Gen Intern Med. 2014 Jul;29 Suppl
2:S675-81. doi: 10.1007/s11606-014-2774-4. 
  </ref>
  <a><pmid>PMID24715403   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Noble K, Brown K, Medina M, Alvarez F, Young J, Leadley S, Kim Y, DiCarlo L.
Medication adherence and activity patterns underlying uncontrolled hypertension: Assessment and recommendations by practicing pharmacists using digital health
care. J Am Pharm Assoc (2003). 2016 May-Jun;56(3):310-5. doi:
10.1016/j.japh.2016.01.005. Epub 2016 Apr 1. 
  </ref>
  <a><pmid>PMID27053077   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Modi RA, McGwin G, Westfall AO, Powell DW, Burkholder GA, Raper JL, Willig JH.
Venous thromboembolism among HIV-positive patients and anticoagulation clinic
outcomes integrated within the HIV primary care setting. Int J STD AIDS. 2015
Oct;26(12):870-8. doi: 10.1177/0956462414561033. Epub 2014 Nov 20. 
  </ref>
  <a><pmid>PMID25414089   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Koenigsfeld CF, Horning KK, Logemann CD, Schmidt GA. Medication therapy management in the primary care setting: a pharmacist-based pay-for-performance project. J Pharm Pract. 2012 Feb;25(1):89-95. Epub 2011 Sep 20. 
  </ref>
  <a><pmid>PMID21933965   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Haynes KT, Oberne A, Cawthon C, Kripalani S. Pharmacists' recommendations to improve care transitions. Ann Pharmacother. 2012 Sep;46(9):1152-9 
  </ref>
  <a><pmid>PMID22872752   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Charrois TL, Zolezzi M, Koshman SL, Pearson G, Makowsky M, Durec T, Tsuyuki RT. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy. 2012 Mar;32(3):222-33. 
  </ref>
  <a><pmid>PMID22392455   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bright DR, Kroustos KR, Thompson RE, Swanson SC, Terrell SL, Dipietro NA. Preliminary results from a multidisciplinary university-based disease state management program focused on hypertension, hyperlipidemia, and diabetes. J Pharm Pract. 2012 Apr;25(2):130-5. 
  </ref>
  <a><pmid>PMID22048927   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm. 2013 Jun;19(5):408-16. Review. PubMed PMID: 23697478. 
  </ref>
  <a><pmid>PMID23697478   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011 Sep 12;171(16):1441-53. doi: 10.1001/archinternmed.2011.399. Review. PubMed PMID: 21911628. 
  </ref>
  <a><pmid>PMID21911628   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Herring H, Smith W, Ripley T, Farmer K. Pharmacist involvement at discharge with the joint commission heart failure core measure: challenges and lessons learned. Hosp Pharm. 2014 Dec;49(11):1017-21. doi: 10.1310/hpj4911-1017. PubMed PMID: 25673890; PubMed Central PMCID: PMC4319801 
  </ref>
  <a><pmid>PMID25673890   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McCarren M, Furmaga E, Jackevicius CA, Sahay A, Coppler TL, Katzianer J, Griffiths RL, Tonnu-Mihara I, Heidenreich P. Improvement of guideline β-blocker prescribing in heart failure: a cluster-randomized pragmatic trial of a pharmacy  intervention. J Card Fail. 2013 Aug;19(8):525-32. doi: 10.1016/j.cardfail.2013.06.004. PubMed PMID: 23910580 
  </ref>
  <a><pmid>PMID23910580   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fanous AM, Kier KL, Rush MJ, Terrell S. Impact of a 12-week, pharmacist-directed walking program in an established employee preventive care clinic. Am J Health Syst Pharm. 2014 Jul 15;71(14):1219-25. doi: 10.2146/ajhp130484. PubMed PMID: 24973382 
  </ref>
  <a><pmid>PMID24973382   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Saleem F, Hassali MA, Shafie AA, Ul Haq N, Farooqui M, Aljadhay H, Ahmad FU.
Pharmacist intervention in improving hypertension-related knowledge, treatment
medication adherence and health-related quality of life: a non-clinical
randomized controlled trial. Health Expect. 2015 Oct;18(5):1270-81. doi:
10.1111/hex.12101. Epub 2013 Jun 20. 
  </ref>
  <a><pmid>PMID23786500   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Irons BK, Meyerrose G, Laguardia S, Hazel K, Seifert CF. A collaborative
cardiologist-pharmacist care model to improve hypertension management in patients
with or at high risk for cardiovascular disease. Pharm Pract (Granada). 2012
Jan;10(1):25-32. Epub 2012 Mar 31. 
  </ref>
  <a><pmid>PMID24155813   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ripley TL, Hennebry TA, Sanders TN, Harrison D, Rathbun RC. Impact of a
clinical pharmacist on a cardiovascular surrogate endpoint: a pilot study. Pharm Pract (Granada). 2012 Jul;10(3):173-9. Epub 2012 Sep 30. 
  </ref>
  <a><pmid>PMID24155834   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010  
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Garcia BH, Giverhaug T, Høgli JU, Skjold F, Småbrekke L. A pharmacist-led
follow-up program for patients with established coronary heart disease in North
Norway - a randomized controlled trial. Pharm Pract (Granada). 2015
Apr-Jun;13(2):575. Epub 2015 Jun 15. 
  </ref>
  <a><pmid>PMID26131047   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Anchah L, Hassali MA, Lim MS, Ibrahim MI, Sim KH, Ong TK. Health related
quality of life assessment in acute coronary syndrome patients: the effectiveness
of early phase I cardiac rehabilitation. Health Qual Life Outcomes. 2017 Jan
13;15(1):10. doi: 10.1186/s12955-016-0583-7. 
  </ref>
  <a><pmid>PMID28086784   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bell SP, Schnipper JL, Goggins K, Bian A, Shintani A, Roumie CL, Dalal AK,
Jacobson TA, Rask KJ, Vaccarino V, Gandhi TK, Labonville SA, Johnson D, Neal EB, Kripalani S; Pharmacist Intervention for Low Literacy in Cardiovascular Disease
(PILL-CVD) Study Group. Effect of Pharmacist Counseling Intervention on Health
Care Utilization Following Hospital Discharge: A Randomized Control Trial. J Gen Intern Med. 2016 May;31(5):470-7. doi: 10.1007/s11606-016-3596-3. 
  </ref>
  <a><pmid>PMID26883526   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Martínez López I, Do Pazo-Oubiña F, Lozano Vilardell P. Comprehensive pharmaceutical care in a vascular surgery department. Farm Hosp. 2011 Sep-Oct;35(5):260-3. 
  </ref>
  <a><pmid>PMID21798782   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen LaPointe NM. Patient-focused intervention to improve long-term adherence to evidence-based
medications: a randomized trial. Am Heart J. 2012 Apr;163(4):657-65.e1. doi:
10.1016/j.ahj.2012.01.019. 
  </ref>
  <a><pmid>PMID22520532   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Villa LA, Von Chrismar AM, Oyarzun C, Eujenin P, Fernandez ME, Quezada M. Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes. Lat Am J Pharm. 2009;28:415–20. 
  </ref>
  <a><pmid>LID100   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Smith MC, Boldt AS, Walston CM, Zillich AJ. Effectiveness of a pharmacy care management program for veterans with dyslipidemia. Pharmacotherapy. 2013 Jul;33(7):736-43. 
  </ref>
  <a><pmid>PMID23625745   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. Am J Health Syst Pharm. 2011 Feb 1;68(3):241-53. 
  </ref>
  <a><pmid>PMID21258029   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernández D. Impact of a community pharmacists' hypertension-care service on medication adherence : The AFenPA study. Res Social Adm Pharm. 2013 Feb 4. 
  </ref>
  <a><pmid>PMID23391845   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Alsina DG, Sabater-Hernández D. Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure control in hypertensive patients. Am J Health Syst Pharm. 2012 Aug 1;69(15):1311-8. 
  </ref>
  <a><pmid>PMID22821790   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011 Feb;33(1):132-40. 
  </ref>
  <a><pmid>PMID21365405   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009 Oct 26;169(19):1748-55 
  </ref>
  <a><pmid>PMID19858431   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aguiar PM, Balisa-Rocha BJ, Brito GC, Lyra DP Jr. Pharmaceutical care program for elderly patients with uncontrolled hypertension. J Am Pharm Assoc (2003). 2012 Jul-Aug;52(4):515-8, 1 p following 518 
  </ref>
  <a><pmid>PMID22825232   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chan CW, Siu SC, Wong CK, Lee VW. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):57-64. 
  </ref>
  <a><pmid>PMID21335480   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Johnson SG. Improving cost-effectiveness of and outcomes from drug therapy in patients with atrial fibrillation in managed care: role of the pharmacist. J Manag Care Pharm. 2009 Aug;15(6 Suppl B):S19-25. 
  </ref>
  <a><pmid>PMID19678723   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lalonde L, Goudreau J, Hudon É, Lussier MT, Duhamel F, Bélanger D, Lévesque L, Martin É; Group for TRANSIT to Best Practices in Cardiovascular Disease Prevention in Primary Care. Priorities for action to improve cardiovascular preventive care of patients with multimorbid conditions in primary care--a participatory action research project. Fam Pract. 2012 Dec;29(6):733-41. doi: 10.1093/fampra/cms021. Epub 2012 Feb 29. 
  </ref>
  <a><pmid>PMID22379187   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev. 2013 Feb 28;2:CD010398. doi: 10.1002/14651858.CD010398. Review. PubMed PMID: 23450614 
  </ref>
  <a><pmid>PMID23450614   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Svarstad BL, Kotchen JM, Shireman TI, Brown RL, Crawford SY, Mount JK, Palmer PA, Vivian EM, Wilson DA. Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial. J Am Pharm Assoc (2003). 2013 Sep-Oct;53(5):520-9. doi: 10.1331/JAPhA.2013.12246. PubMed PMID: 24030130 
  </ref>
  <a><pmid>PMID24030130   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ploylearmsang C, Sookaneknun P, Poophalee T, Pongruea P. Diabetes and hypertension screening by pharmacy students in Thai communities. Am J Pharm Educ. 2013 Apr 12;77(3):56. doi: 10.5688/ajpe77356. PubMed PMID: 23610474; PubMed Central PMCID: PMC3631731. 
  </ref>
  <a><pmid>PMID23610474   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Obreli-Neto PR, Marusic S, Guidoni CM, Baldoni Ade O, Renovato RD, Pilger D,
Cuman RK, Pereira LR. Economic evaluation of a pharmaceutical care program for
elderly diabetic and hypertensive patients in primary health care: a 36-month
randomized controlled clinical trial. J Manag Care Spec Pharm. 2015
Jan;21(1):66-75. 
  </ref>
  <a><pmid>PMID25562774   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):408-11. 
  </ref>
  <a><pmid>PMID18312492   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kroner BA, Billups SJ, Garrison KM, Lyman AE, Delate T. Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system. J Manag Care Pharm. 2008 Mar;14(2):155-63. 
  </ref>
  <a><pmid>PMID18331117   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kripalani S, Roumie CL, Dalal AK, Cawthon C, Businger A, Eden SK, Shintani A, Sponsler KC, Harris LJ, Theobald C, Huang RL, Scheurer D, Hunt S, Jacobson TA, Rask KJ, Vaccarino V, Gandhi TK, Bates DW, Williams MV, Schnipper JL; PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012 Jul 3;157(1):1-10. 
  </ref>
  <a><pmid>PMID22751755   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008 Apr 14;168(7):687-94. 
  </ref>
  <a><pmid>PMID18413550   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Salanitro AH, Osborn CY, Schnipper JL, Roumie CL, Labonville S, Johnson DC, Neal E, Cawthon C, Businger A, Dalal AK, Kripalani S. Effect of patient- and medication-related factors on inpatient medication reconciliation errors. J Gen Intern Med. 2012 Aug;27(8):924-32. 
  </ref>
  <a><pmid>PMID22350761   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues MA, Bayes-Genis A. Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic. J Card Fail. 2011 Mar;17(3):217-23. 
  </ref>
  <a><pmid>PMID21362530   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dolder NM, Dolder CR. Comparison of a pharmacist-managed lipid clinic:
in-person versus telephone. J Am Pharm Assoc (2003). 2010 May-Jun;50(3):375-8.
doi: 10.1331/JAPhA.2010.09048. 
  </ref>
  <a><pmid>PMID20452911   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Peterson ED, Albert NM, Amin A, Patterson JH, Fonarow GC. Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management. Am J Cardiol. 2008 Sep 8;102(5A):47G-56G. 
  </ref>
  <a><pmid>PMID18722192   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hassan Y, Kassab Y, Abd Aziz N, Akram H, Ismail O. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge. J Clin Pharm Ther. 2013 Apr;38(2):97-100. 
  </ref>
  <a><pmid>PMID23441979   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fabbio KL, Bradley M, Chrymko M. Evaluation of a pharmacist-managed telephone lipid clinic at a Veterans Affairs Medical Center. Ann Pharmacother. 2010 Jan;44(1):50-6. 
  </ref>
  <a><pmid>PMID20028961   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Villeneuve J, Genest J, Blais L, Vanier MC, Lamarre D, Fredette M, Lussier MT, Perreault S, Hudon E, Berbiche D, Lalonde L. A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study. CMAJ. 2010 Mar 23;182(5):447-55. 
  </ref>
  <a><pmid>PMID20212029   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tahaineh L, Albsoul-Younes A, Al-Ashqar E, Habeb A. The role of clinical pharmacist on lipid control in dyslipidemic patients in North of Jordan. Int J Clin Pharm. 2011 Apr;33(2):229-36. 
  </ref>
  <a><pmid>PMID21744191   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gerrald KR, Dixon DL, Barnette DJ, Williams VG. Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing. J Clin Lipidol. 2010 Mar-Apr;4(2):120-5. 
  </ref>
  <a><pmid>PMID21122639   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kulchaitanaroaj P, Brooks JM, Ardery G, Newman D, Carter BL. Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control. Pharmacotherapy. 2012 Aug;32(8):772-80. 
  </ref>
  <a><pmid>PMID23307525   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, Touchette D. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008 Dec;23(12):1966-72. 
  </ref>
  <a><pmid>PMID18815843   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lee VW, Yi PT, Kong KW, Chan PK, Kwok FL. Impact of pharmacy outreach services on blood pressure management in the elderly community of Hong Kong. Geriatr Gerontol Int. 2013 Jan;13(1):175-81 
  </ref>
  <a><pmid>PMID22680786   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):157-63. 
  </ref>
  <a><pmid>PMID23463811   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract. 2010 Dec;60(581):e476-88. doi: 10.3399/bjgp10X544113. Review. PubMed PMID: 21144192; PubMed Central PMCID: PMC2991764. 
  </ref>
  <a><pmid>PMID21144192   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chisholm-Burns MA, Graff Zivin JS, Lee JK, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, Abraham I, Palmer J. Economic effects of pharmacists on health outcomes in the United States: A systematic review. Am J Health Syst Pharm. 2010  Oct 1;67(19):1624-34. doi: 10.2146/ajhp100077. Review. PubMed PMID: 20852164. 
  </ref>
  <a><pmid>PMID20852164   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Blizzard S, Verbosky N, Stein B, Hale G, Patel N, Chau Y, Cave B. Evaluation
of Pharmacist Impact Within an Interdisciplinary Inpatient Heart Failure Consult Service. Ann Pharmacother. 2019 Apr 9:1060028019842656. doi:
10.1177/1060028019842656. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30961358   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm. 2007 Apr 15;64(8):842-9. 
  </ref>
  <a><pmid>PMID17420201   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Scott A, Tinelli M, Bond C; Community Pharmacy Medicines Management Evaluation
Team. Costs of a community pharmacist-led medicines management service for
patients with coronary heart disease in England: healthcare system and patient
perspectives. Pharmacoeconomics. 2007;25(5):397-411. 
  </ref>
  <a><pmid>PMID17488138   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Eggink RN, Lenderink AW, Widdershoven JW, van den Bemt PM. The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure. Pharm World Sci. 2010 Dec;32(6):759-66. 
  </ref>
  <a><pmid>PMID20809276   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ponniah A, Anderson B, Shakib S, Doecke CJ, Angley M. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007 Aug;32(4):343-52. 
  </ref>
  <a><pmid>PMID17635336   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McKinnon PS, Seaton T, Noirot LA, Reichley RM, Heard KM, Shannon WD, Goldberg AC, Dunagan WC, Bailey TC. Improving adherence to dyslipidemia medication guidelines in hospitalized diabetic patients using a technology-assisted pharmacist intervention. AMIA Annu Symp Proc. 2008 Nov 6:868. 
  </ref>
  <a><pmid>PMID18999065   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Machado M, Nassor N, Bajcar JM, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions - Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008 Sep;42(9):1195-207. 
  </ref>
  <a><pmid>PMID18682540   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sandhoff BG, Nies LK, Olson KL, Nash JD, Rasmussen JR, Merenich JA. Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization. Am J Health Syst Pharm. 2007 Jan 1;64(1):77-84. 
  </ref>
  <a><pmid>PMID17189584   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bex SD, Boldt AS, Needham SB, Bolf SM, Walston CM, Ramsey DC, Schmelz AN, Zillich AJ. Effectiveness of a hypertension care management program provided by clinical pharmacists for veterans. Pharmacotherapy. 2011 Jan;31(1):31-8 
  </ref>
  <a><pmid>PMID21182356   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005182. doi: 10.1002/14651858.CD005182.pub4. Review. PubMed PMID: 20238338. 
  </ref>
  <a><pmid>PMID20238338   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gallagher H, de Lusignan S, Harris K, Cates C. Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review. Br J Gen Pract. 2010 Jun;60(575):e258-65. doi: 10.3399/bjgp10X502164. Review. PubMed PMID: 20529489; PubMed Central PMCID: PMC2880767. 
  </ref>
  <a><pmid>PMID20529489   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Taveira TH, Wu WC. Interventions to maintain cardiac risk control after discharge from a cardiovascular risk reduction clinic: a randomized controlled trial. Diabetes Res Clin Pract. 2014 Sep;105(3):327-35. doi: 10.1016/j.diabres.2014.05.013. Epub 2014 Jun 10. PubMed PMID: 24969964. 
  </ref>
  <a><pmid>PMID24969964   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Toma MB, Winstead PS, Smith KM, Lewis DA, Clifford TM. Pharmacy resident
participation in cardiopulmonary resuscitation events. Am J Health Syst Pharm.
2007 Apr 1;64(7):747-53. 
  </ref>
  <a><pmid>PMID17384361   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gordon W, Perrott J, Dahri K. Accuracy of medication histories: the first step of medication reconciliation. Ann Pharmacother. 2008 Jan;42(1):144. 
  </ref>
  <a><pmid>PMID18094349   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Castelino RL, Chen TF, Guddattu V, Bajorek BV. Use of evidence-based therapy for the prevention of cardiovascular events among older people. Eval Health Prof.2010 Sep;33(3):276-301. 
  </ref>
  <a><pmid>PMID20801973   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006 Dec 6;296(21):2563-71. 
  </ref>
  <a><pmid>PMID17101639   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Eussen SR, van der Elst ME, Klungel OH, Rompelberg CJ, Garssen J, Oosterveld MH, de Boer A, de Gier JJ, Bouvy ML. A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. Ann Pharmacother. 2010 Dec;44(12):1905-13. 
  </ref>
  <a><pmid>PMID21119098   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lee VW, Fan CS, Li AW, Chau AC. Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong. J Clin Pharm Ther. 2009 Aug;34(4):407-14. 
  </ref>
  <a><pmid>PMID19583673   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions - Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007 Nov;41(11):1770-81. Epub 2007 Oct 9. Review. 
  </ref>
  <a><pmid>PMID17925496   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aguwa CN, Ukwe CV, Ekwunife OI. Effect of pharmaceutical care programme on blood pressure and quality of life in a Nigerian pharmacy. Pharm World Sci. 2008 Jan;30(1):107-10. 
  </ref>
  <a><pmid>PMID17703369   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hennessy S, Leonard CE, Yang W, Kimmel SE, Townsend RR, Wasserstein AG, Ten Have TR, Bilker WB. Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial. Pharmacotherapy. 2006 Sep;26(9):1342-7. 
  </ref>
  <a><pmid>PMID16945057   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     de Castro MS, Fuchs FD, Santos MC, Maximiliano P, Gus M, Moreira LB, Ferreira MB. Pharmaceutical care program for patients with uncontrolled hypertension : Report of a double-blind clinical trial with ambulatory blood pressure monitoring. Am J Hypertens. 2006 May;19(5):528-33 
  </ref>
  <a><pmid>PMID16647628   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bond CA, Raehl CL. 2006 national clinical pharmacy services survey: clinical
pharmacy services, collaborative drug management, medication errors, and pharmacy
technology. Pharmacotherapy. 2008 Jan;28(1):1-13. 
  </ref>
  <a><pmid>PMID18154468   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E. Effect of
intervention through a pharmaceutical care program on patient adherence with
prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf. 2006
Feb;15(2):115-21. 
  </ref>
  <a><pmid>PMID16342302   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005 Aug;60(2):183-93. 
  </ref>
  <a><pmid>PMID16042672   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jain A, Mills P, Nunn LM, Butler J, Luddington L, Ross V, Cliffe P, Ranjadayalan K, Timmis AD. Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents. Eur J Heart Fail. 2005 Mar 16;7(3):405-10. 
  </ref>
  <a><pmid>PMID15718181   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Horning KK, Hoehns JD, Doucette WR. Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review. J Manag Care Pharm. 2007 Jan-Feb;13(1):28-36. 
  </ref>
  <a><pmid>PMID17269834   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yu DS, Thompson DR, Lee DT. Disease management programmes for older people with heart failure: crucial characteristics which improve post-discharge outcomes. Eur Heart J. 2006 Mar;27(5):596-612. 
  </ref>
  <a><pmid>PMID16299021   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Olson KL, Delate T, Rasmussen J, Humphries TL, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group. Outcomes of patients discharged from pharmacy-managed cardiovascular disease management. Am J Manag Care. 2009 Aug;15(8):497-503. 
  </ref>
  <a><pmid>PMID19670953   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Donovan JL, Schroeder WS, Tran MT, Foster K, Forrest A, Lee TB, Gandhi PJ. Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists. J Manag Care Pharm. 2007 Sep;13(7):598-606. 
  </ref>
  <a><pmid>PMID17874866   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kaczorowski J, Chambers LW, Dolovich L, Paterson JM, Karwalajtys T, Gierman T, Farrell B, McDonough B, Thabane L, Tu K, Zagorski B, Goeree R, Levitt CA, Hogg W, Laryea S, Carter MA, Cross D, Sabaldt RJ. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ. 2011 Feb 7;342:d442. doi: 10.1136/bmj.d442. 
  </ref>
  <a><pmid>PMID21300712   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Acquisto NM, Hays DP, Fairbanks RJ, Shah MN, Delehanty J, Nobay F, Guido J, Haas CE. The outcomes of emergency pharmacist participation during acute myocardial infarction. J Emerg Med. 2012 Apr;42(4):371-8. 
  </ref>
  <a><pmid>PMID20813484   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Loughlin SM, Mortazavi A, Garey KW, Rice GK, Birtcher KK. Pharmacist-managed vaccination program increased influenza vaccination rates in cardiovascular patients enrolled in a secondary prevention lipid clinic. Pharmacotherapy. 2007 May;27(5):729-33. 
  </ref>
  <a><pmid>PMID17461708   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Yamada C, Johnson JA, Robertson P, Pearson G, Tsuyuki RT. Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus). Pharmacotherapy. 2005 Jan;25(1):110-5. 
  </ref>
  <a><pmid>PMID15767226   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chung JS, Lee KK, Tomlinson B, Lee VW. Clinical and economic impact of clinical pharmacy service on hyperlipidemic management in Hong Kong. J Cardiovasc Pharmacol Ther. 2011 Mar;16(1):43-52. 
  </ref>
  <a><pmid>PMID20924095   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Paulós CP, Nygren CE, Celedón C, Cárcamo CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother. 2005 May;39(5):939-43. 
  </ref>
  <a><pmid>PMID15827075   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT; SCRIP-HTN Investigators. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008 Nov 24;168(21):2355-61. 
  </ref>
  <a><pmid>PMID19029501   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mino-León D, Reyes-Morales H, Flores-Hernández S. Effectiveness of involving
pharmacists in the process of ambulatory health care to improve drug treatment
adherence and disease control. J Eval Clin Pract. 2015 Feb;21(1):7-12. doi:
10.1111/jep.12207. Epub 2014 Jun 21. 
  </ref>
  <a><pmid>PMID24953287   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, Rae B, McMurray JJ; Heart Failure Optimal Outcomes from Pharmacy Study (HOOPS)Investigators. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2012Feb;33(3):314-24. 
  </ref>
  <a><pmid>PMID22083873   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, Killer G, Gilbert AL. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail. 2009 Sep;2(5):424-8. 
  </ref>
  <a><pmid>PMID19808372   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Murray MD, Young JM, Morrow DG, Weiner M, Tu W, Hoke SC, Clark DO, Stroupe KT, Wu J, Deer MM, Bruner-England TE, Sowinski KM, Smith FE, Oldridge NB, Gradus-Pizlo I, Murray LL, Brater DC, Weinberger M. Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. Am J Geriatr Pharmacother. 2004 Mar;2(1):53-65. 
  </ref>
  <a><pmid>PMID15555479   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart. 2005 Jul;91(7):899-906. 
  </ref>
  <a><pmid>PMID15958358   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009 Jul;29(7):761-8. 
  </ref>
  <a><pmid>PMID19558249   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tsuyuki RT, Olson KL, Dubyk AM, Schindel TJ, Johnson JA. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus). Am J Med. 2004 Jan 15;116(2):130-3. 
  </ref>
  <a><pmid>PMID14715327   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Collins C, Kramer A, O'Day ME, Low MB. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Am J Health Syst Pharm. 2006 Sep 15;63(18):1723-7. 
  </ref>
  <a><pmid>PMID16960256   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, Hartz AJ. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008 Apr;10(4):260-71 
  </ref>
  <a><pmid>PMID18401223   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fahey T, Schroeder K, Ebrahim S. Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract. 2005 Nov;55(520):875-82. Review. 
  </ref>
  <a><pmid>PMID16282005   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     John EJ, Vavra T, Farris K, Currie J, Doucette W, Button-Neumann B, Osterhaus M, Kumbera P, Halterman T, Bullock T. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight. Pharmacotherapy. 2006 Oct;26(10):1511-7. 
  </ref>
  <a><pmid>PMID16999661   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Triller DM, Hamilton RA. Effect of pharmaceutical care services on outcomes
for home care patients with heart failure. Am J Health Syst Pharm. 2007 Nov
1;64(21):2244-9. 
  </ref>
  <a><pmid>PMID17959576   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ulfvarson J, Adami J, Ullman B, Wredling R, Reilly M, von Bahr C. Randomized controlled intervention in cardiovascular drug treatment in nursing homes. Pharmacoepidemiol Drug Saf. 2003 Oct-Nov;12(7):589-93. 
  </ref>
  <a><pmid>PMID14558182   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, Lipp A, Daly C, Howe A, Hall R, Harvey I. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ. 2007 May 26;334(7603):1098. 
  </ref>
  <a><pmid>PMID17452390   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Coons JC, Fera T. Multidisciplinary team for enhancing care for patients with acute myocardial infarction or heart failure. Am J Health Syst Pharm. 2007 Jun;64(12):1274-8. 
  </ref>
  <a><pmid>PMID17563049   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004 Aug 18;44(4):810-9. 
  </ref>
  <a><pmid>PMID15312864   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ganachari MS, Pawar SB. Counseling patients with myocardial infarction in India. Am J Health Syst Pharm. 2004 Jun 1;61(11):1182, 1185. 
  </ref>
  <a><pmid>PMID15237573   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mazzolini TA, Irons BK, Schell EC, Seifert CF. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers. J Manag Care Pharm. 2005 Nov-Dec;11(9):763-71. 
  </ref>
  <a><pmid>PMID16300420   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     de Souza WA, Yugar-Toledo JC, Bergsten-Mendes G, Sabha M, Moreno H Jr. Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. Am J Health Syst Pharm. 2007 Sep 15;64(18):1955-61. 
  </ref>
  <a><pmid>PMID17823108   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2003 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Weber E, Hepfinger C, Koontz R, Cohn-Oswald L. Pharmacy technicians supporting
clinical functions. Am J Health Syst Pharm. 2005 Dec 1;62(23):2466-72. 
  </ref>
  <a><pmid>PMID16303900   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Meredith S, Feldman P, Frey D, Giammarco L, Hall K, Arnold K, Brown NJ, Ray WA. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc. 2002 Sep;50(9):1484-91. 
  </ref>
  <a><pmid>PMID12383144   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Patel K, Sansgiry SS, Miller L. Pharmacist participation in home health heart-failure programs. Am J Health Syst Pharm. 2003 Nov 1;60(21):2259-60 
  </ref>
  <a><pmid>PMID14619124   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     O'Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother. 2005 Sep;39(9):1423-7. 
  </ref>
  <a><pmid>PMID16046491   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chapman NR, Fotis MA, Yarnold PR, Gheorghiade M. Pharmacist interventions to improve the management of coronary artery disease. Am J Health Syst Pharm. 2004 Dec 15;61(24):2672-8. 
  </ref>
  <a><pmid>PMID15646702   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Olson KL, Rasmussen J, Sandhoff BJ, Merenich JA. A global and sustained approach to lipid management of 8,014 patients with coronary artery disease: the 5-year Colorado Kaiser Permanente clinical pharmacy cardiac risk service (CPCRS)experience. Arch Intern Med. 2005;165:49–54. 
  </ref>
  <a><pmid>LID102   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lee SS, Cheung PY, Chow MS. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. J Clin Pharmacol. 2004 Jun;44(6):632-9. 
  </ref>
  <a><pmid>PMID15145971   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     McConnell KJ, Zadvorny EB, Hardy AM, Delate T, Rasmussen JR, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group. Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program. Pharmacotherapy. 2006 Sep;26(9):1333-41 
  </ref>
  <a><pmid>PMID16945056   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007 May 15;146(10):714-25. 
  </ref>
  <a><pmid>PMID17502632   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Noureldin M, Plake KS, Morrow DG, Tu W, Wu J, Murray MD. Effect of health
literacy on drug adherence in patients with heart failure. Pharmacotherapy. 2012 Sep;32(9):819-26. 
  </ref>
  <a><pmid>PMID22744746   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Till LT, Voris JC, Horst JB. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. J Manag Care Pharm. 2003 May-Jun;9(3):269-73. 
  </ref>
  <a><pmid>PMID14613471   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H. Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther. 2004 Feb;29(1):23-30. 
  </ref>
  <a><pmid>PMID14748894   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Santschi V, Rodondi N, Bugnon O, Pannatier A, Burnier M. [Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians]. Rev Med Suisse. 2008 Sep 10;4(170):1928, 1930-2, 1934 passim. 
  </ref>
  <a><pmid>PMID18847122   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003 Jun;25(2):144-53. Review. PubMed PMID: 12848404. 
  </ref>
  <a><pmid>PMID12848404   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed
hypertension clinic. Pharmacotherapy. 2001 Nov;21(11):1337-44. 
  </ref>
  <a><pmid>PMID11714206   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in geriatric ambulatory clinic. Pharmacotherapy. 2000 Oct;20(10):1198-203. 
  </ref>
  <a><pmid>PMID11034043   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     López Cabezas C, Falces Salvador C, Cubí Quadrada D, Arnau Bartés A, Ylla Boré M, Muro Perea N, Homs Peipoch E. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. Farm Hosp. 2006 Nov-Dec;30(6):328-42. 
  </ref>
  <a><pmid>PMID17298190   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lieutenant Colonel Régis Vaillancourt, L Maria Gutschi, Janice Ma, Major Shannon Sinclair, and Danette Beechinor. Pharmacist-Managed Lipid Clinics: Development and Implementation in the Canadian Forces. Can J Hosp Pharm. 2003;56:24-31 
  </ref>
  <a><pmid>LID236   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, Braverman A, Goldberg A, Waterman B, Dunagan WC. An intervention to improve secondary prevention of coronary heart disease. Arch Intern Med. 2007 Mar 26;167(6):586-90. 
  </ref>
  <a><pmid>PMID17389290   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Muhlestein JB. Strategies to increase HMG-CoA reductase inhibitor use after acute myocardial infarction. Drugs Aging. 2004;21(9):583-95. Review. 
  </ref>
  <a><pmid>PMID15260513   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, Barnette DJ, Sintek CD, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Dombrowski R, Geraets DR, Amato M. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study: Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000 Dec;20(12):1508-16. 
  </ref>
  <a><pmid>PMID11130223   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000 Apr;20(4):410-6. 
  </ref>
  <a><pmid>PMID10772372   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2000 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ali F, Laurin MY, Larivière C, Tremblay D, Cloutier D. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol. 2003 Fall;10(3):101-6. 
  </ref>
  <a><pmid>PMID14506507   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1999 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999 Jul;19(7):860-9. 
  </ref>
  <a><pmid>PMID10417035   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1999 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stewart S, Vandenbroek AJ, Pearson S, Horowitz JD. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med. 1999 Feb 8;159(3):257-61. 
  </ref>
  <a><pmid>PMID9989537   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1999 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tsuyuki RT, Fradette M, Johnson JA, Bungard TJ, Eurich DT, Ashton T, Gordon W, Ikuta R, Kornder J, Mackay E, Manyari D, O'Reilly K, Semchuk W. A multicenter disease management program for hospitalized patients with heart failure. J Card Fail. 2004 Dec;10(6):473-80. 
  </ref>
  <a><pmid>PMID15599837   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1999 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chinwong S, Reid F, McGlynn S, Hudson S, Flapan A. The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients. Pharm World Sci. 2004 Apr;26(2):96-101. 
  </ref>
  <a><pmid>PMID15085944   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1999 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     O'Donnell DC, Chen NT, Piziak VK. Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic. Am J Health Syst Pharm. 2001 Feb 15;58(4):325-30. 
  </ref>
  <a><pmid>PMID11225170   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Turner CJ, Parfrey P, Ryan K, Miller R, Brown A. Community pharmacist outreach program directed at physicians treating congestive heart failure. Am J Health Syst Pharm. 2000 Apr 15;57(8):747-52. 
  </ref>
  <a><pmid>PMID10786260   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoes AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003 Oct;9(5):404-11. Erratum in: J Card Fail. 2003 Dec;9(6):481. 
  </ref>
  <a><pmid>PMID14583903   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bucci C, Jackevicius C, McFarlane K, Liu P. Pharmacist's contribution in a heart function clinic: patient perception and medication appropriateness. Can J Cardiol. 2003 Mar 31;19(4):391-6. 
  </ref>
  <a><pmid>PMID12704485   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gwadry-Sridhar FH, Arnold JM, Zhang Y, Brown JE, Marchiori G, Guyatt G. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J. 2005 Nov;150(5):982. 
  </ref>
  <a><pmid>PMID16290975   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998 May 25;158(10):1067-72 
  </ref>
  <a><pmid>PMID9605777   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Whellan DJ, Gaulden L, Gattis WA, Granger B, Russell SD, Blazing MA, Cuffe MS, O'Connor CM. The benefit of implementing a heart failure disease management program. Arch Intern Med. 2001 Oct 8;161(18):2223-8. 
  </ref>
  <a><pmid>PMID11575979   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Axtell SS, Ludwig E, Lope-Candales P. Intervention to improve adherence to ACC/AHA recommended adjunctive medications for the management of patients with an acute myocardial infarction. Clin Cardiol. 2001 Feb;24(2):114-8. 
  </ref>
  <a><pmid>PMID11214740   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hilleman DE, Faulkner MA, Monaghan MS. Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia. Pharmacotherapy. 2004 Aug;24(8):1077-83. 
  </ref>
  <a><pmid>PMID15338855   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Taylor JG. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002 May 27;162(10):1149-55. 
  </ref>
  <a><pmid>PMID12020186   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy. 2001 May;21(5):627-35. 
  </ref>
  <a><pmid>PMID11349751   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm. 2003 Jun 1;60(11):1123-9. 
  </ref>
  <a><pmid>PMID12816022   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Tsuyuki RT, Johnson JA, Teo KK, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Simpson SH, Taylor JG. Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk. Ann Pharmacother. 1999 Sep;33(9):910-9. 
  </ref>
  <a><pmid>PMID10492489   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bozovich M, Rubino CM, Edmunds J. Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy. 2000 Nov;20(11):1375-83. 
  </ref>
  <a><pmid>PMID11079286   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Côté I, Moisan J, Chabot I, Grégoire JP. Health-related quality of life in hypertension: impact of a pharmacy intervention programme. J Clin Pharm Ther. 2005 Aug;30(4):355-62 
  </ref>
  <a><pmid>PMID15985049   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chabot I, Moisan J, Grégoire JP, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother. 2003 Sep;37(9):1186-93. 
  </ref>
  <a><pmid>PMID12921497   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1998 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Côté I, Grégoire JP, Moisan J, Chabot I, Lacroix G. A pharmacy-based health promotion programme in hypertension: cost-benefit analysis. Pharmacoeconomics. 2003;21(6):415-28 
  </ref>
  <a><pmid>PMID12678568   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm. 1999 Jul 1;56(13):1339-42. 
  </ref>
  <a><pmid>PMID10683133   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Merenich JA, Olson KL, Delate T, Rasmussen J, Helling DK, Ward DG; Clinical Pharmacy Cardiac Risk Service Study Group. Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease. Pharmacotherapy. 2007 Oct;27(10):1370-8. 
  </ref>
  <a><pmid>PMID17896892   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Merenich JA, Lousberg TR, Brennan SH, Calonge NB. Optimizing treatment of dyslipidemia in patients with coronary artery disease in the managed-care environment (the Rocky Mountain Kaiser Permanente experience). Am J Cardiol. 2000 Feb 10;85(3A):36A-42A. 
  </ref>
  <a><pmid>PMID10695706   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cheah J. Development and implementation of a clinical pathway programme in an acute care general hospital in Singapore. Int J Qual Health Care. 2000 Oct;12(5):403-12. 
  </ref>
  <a><pmid>PMID11079220   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1995 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Linné AB, Liedholm H, Israelsson B. Effects of systematic education on heart failure patients knowledge after 6 months: A randomised, controlled trial. Eur J Heart Fail. 1999 Aug;1(3):219-27. 
  </ref>
  <a><pmid>PMID10935668   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1995 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure?. Br J Clin Pract. 1995 Jul-Aug;49(4):173-6. 
  </ref>
  <a><pmid>PMID7547154   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     -- 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Zillich AJ, Jaynes HA, Bex SD, Boldt AS, Walston CM, Ramsey DC, Sutherland JM, Bravata DM. Evaluation of pharmacist care for hypertension in the Veterans Affairs patient-centered medical home: a retrospective case-control study. Am J Med. 2015 May;128(5):539.e1-6. doi: 10.1016/j.amjmed.2014.11.027. Epub 2014 Dec 20. PubMed PMID: 25534422 
  </ref>
  <a><pmid>PMID25534422   </pmid></a> 
</dd> 
</dl>